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Pressure ulcers (PUs) present intrinsic risk factors that are not consistently identified by 
clinical assessments. The objective of this project was to develop a clinical practice 
guideline (CPG) to provide nurses with guidance in identifying and differentiating how 
intrinsic and extrinsic risk factors are associated with populations at risk for developing 
avoidable and unavoidable PUs. CPG development followed a systematic method to 
search the literature, organize findings, and assess the strength of the resulting evidence 
and its applicability to the CPG. Quality of the CPG was assessed by a panel of 8 health 
care professionals using the Appraisal of Guidelines for Research & Evaluation II 
instrument. Findings of the assessment indicated a high overall quality of the CPG; its 
immediate use was recommended and systematic evaluation was suggested to promote 
usage in a wider array of health care contexts. The quality domains with the highest 
scores were scope, purpose, applicability, editorial independence (all 100%), rigor of 
development (99.7%), and clarity of presentation (99.3%). The stakeholder involvement 
domain demonstrated the lowest--yet still robust--score (94.4%). The CPG can be used to 
emphasize appropriate and specific nursing competencies for making informed decisions 
when identifying and describing patients at risk for developing PUs. Further research and 
evaluation of the use of this CPG will be useful to demonstrate how CPGs can help to 
decrease the incidence of avoidable PUs. The potential for positive social change relative 
to the prevention of PUs is high. Decreased incidence of preventable PUs will eliminate 
unnecessary health care costs and improve overall health outcomes of patients at all 
levels of socioeconomic status. 
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Section 1: Nature of the Project   
Introduction 
 General preventive measures for pressure ulcers (pressure injuries) begin with the 
identification of risk factors for, and the etiology of, preventable (avoidable) and not 
preventable (unavoidable) pressure ulcers (PUs). Nurses need to be more knowledgeable 
of the main characteristics of patients at risk for PUs. Knowledge gained allows to make 
a difference in an accurate prognosis and preventing possible PUs/PIs (Pressure Ulcer 
Prevention Toolkit: Joint Commission Resources, 2012). National and International 
discussion among wound care experts and providers has continued to whether all PUs/PIs 
are preventable (WOCN, 2009; Edsberg et al., 2014). Pressure ulcer incidence rates 
continue steady, representing the failure of known, preventative treatment and strategies 
in certain patients (Thomas, 2003). These findings raise the question whether all PUs are 
avoidable. Descriptions of avoidable versus unavoidable PUs for the hospital setting have 
not been implemented officially by regulatory organizations. On the other hand, the 
Centers for Medicare and Medicaid Services (CMS) has published a statement that 
“pressure ulcers should be prevented in residents of long-term care settings, except in the 
case of patients whose clinical condition validates that they were unavoidable” (CMS, 
2004). The National Pressure Ulcer Advisory Panel (NPUAP) has agreed that not all PUs 
are preventable (2010). 
 The NPUAP stated that there are clinical situations in which the development of 
PUs may be unavoidable (NPAUP, 2010). In February 2014, a national expert consensus 




avoidable/unavoidable hospital-acquired PUs (HAPUs) using an organ system framework 
and considering the complexities of no modifiable intrinsic and extrinsic risk factors. An 
extensive literature review was conducted to analyze and synthesize the state of the 
science in the area of unavoidable PU development. An interactive consensus was 
reached among participants of other organizations and audience members. The group 
determined that unavoidable PUs do occur (Edsberg et al; 2014). Findings of this 
conference became the foundation for the NPUAP’s Pressure Ulcer Registry, the first 
database of its type to allow clinicians to input cases of PUs in an effort to provide 
statistically significant, rigorous analysis of the variables associated with the 
development of unavoidable PUs. Unanimously, participants voted that not all PUs are 
avoidable because the patients’ health status may prevent pressure relief, and perfusion 
cannot be improved (Black et al; 2011).  
 The NPUAP has conducted the 2 international consensus conferences on PU 
avoidability-unavoidability. The first conference in 2010 established consensus on the 
existence of some selected situations where PU development can be considered 
unavoidable. Based on an extensive review of the scientific literature on pressure ulcer 
risk factors and PU development, this 2014 conference established consensus on some 
risk factors that, in some selected situations, have been shown to increase the likelihood 
of the development of an unavoidable pressure ulcer. The effort from these pioneering 
conferences continues to define additional conditions associated with the development of 
an unavoidable PU. Using the CMS’s definitions, the NPUAP defined unavoidable PUs 




condition and pressure ulcer risk factors; (b) defined and implemented interventions 
consistent with individual needs, goals, and recognized standards of practice; (c) 
monitored and evaluated the impact of the interventions; and (d) revised the approaches 
as appropriate (NPUAP, 2010; Black et al., 2011). Although this definition is applicable 
and useful, it is conceptual rather than operational and does not provide practical 
application (Pittman et al., 2016). 
 The Wound, Ostomy and Continence Nurses (WOCN) Society also issued a 
position statement on avoidable versus unavoidable PUs, stating that the pressure ulcer 
process is complex, multifactorial, and cannot always be halted (WOCN, 2009). The 
WOCN Society recommended further research to examine the implications of modifiable 
and unmodifiable risk factors in pressure ulcer development and the implications for 
clinical practice (2017). Recognizing the clinical complexities and high incidence of 
comorbidities frequently faced in today’s clinical setting, it is realistic to say that not all 
PUs can be defined as avoidable or preventable (Schmitt et al., 2017). 
Problem Statement 
 Each year, more than 2.5 million people in the United States develop PUs (CMS, 
2009). These skin lesions bring adverse outcomes in patients that may include pain, risk 
of developing an associated serious infection, and increased health care utilization and 
costs [citation needed]. The cost of care may surpass $70,000 and treatment in the U.S. is 
estimated at $11 billion annually. A 5-year study, which included older patients admitted 
to hospital in Ontario, Canada, determined the adjusted net cost to be $44,000 and 




(Chan et al. 2013). The population at risk of PUs is expected to grow given the increase 
of an aging population and the incidence of impaired mobility and chronic conditions, 
such as diabetes and obesity (Bennett et al., 2004; Sullivan & Schoelles, 2013). The 
successful preventive measures cannot be applied if individuals are not correctly 
classified as being at risk. Risk-screening tools are inadequate if they: (a) are not related 
to the population being screened, (b) do not accurately describe for significant risk 
factors, (c) are not used consistently, or 4) are scored erroneously (Thomas, 2001; 
Papanikolaou, Lyne, & Anthony, 2007).  
 The most controversial aspect of PUs is that of avoidability. It is recognized that 
PUs etiology is a complex process that involves multiple, often non-modifiable, intrinsic 
risk factors, which are not fully identified by pressure ulcer risk assessment scales 
(Berlowitz & Brienza, 2007; Edsberg et al., 2014; Lyder, 2003; Registered Nurses 
Association of Ontario [RNAO], 2011). More than 100 risk factors associated with 
pressure ulcer development have been identified (Anderson et al., 2015). The quantity 
and diversity of risk factors challenge the clinician to choose and apply applicable 
preventive interventions in a timely fashion. The process is not fully understood, but it 
seems rational that the greater the number of risk factors present, the greater challenge it 
will be to prevent the development and/or deterioration of PUs (Lyder et al., 2012). 
 There is a need to expand the knowledge for determining avoidable versus 
unavoidable PUs and validate best practices to reduce the incidence of avoidable PUs 
(WOCN, 2009). Expert recommend the following:  endorse the basic components of 




management (i.e., skin assessment, description of skin integrity, identification of extrinsic 
and intrinsic risk factors for pressure ulcer development, including hemodynamics and 
comorbidities); and determine the role of validated instruments, computer-based 
algorithms, digital technology, ultrasound, and other modalities for assessment and 
documentation (Alvey, Hennen, & Heard, 2012; NPUAP et al., 2014; Pittman et al., 
2016).  
 The problem addressed in this project is the lack of an evidence-based clinical 
guideline that help nurses identify, describe, and document the modifiable and non-
modifiable risk factors associated with the development of avoidable (preventable) versus 
unavoidable (non-preventable) PUs. New models and best practices are crucial to help 
determine which PUs are unavoidable (Anderson et al., 2015; Levin et at; 2009). 
Assessing at-risk patients requires a decision process, including understanding numerous 
characteristics of a patient’s status (Choi et al., 2014). PUs are considered to be an 
avoidable injury and continue be a key quality indicator (National Patient Safety Agency 
[NPSA] 2010; NHS Improving Quality, 2014); as the goal to prevent PUs remains 
essential, the number of PUs classified as preventable remains uncertain. CMS advises 
that nurses consider all risk factors independent of the scores obtained on any validated 
pressure ulcer prediction scales, because not all factors are found on any one tool. The 
WOCN Society supports further research and quality improvement proposals to expand 
the science and understanding in differentiating avoidable and unavoidable PUs, 
identifying etiological factors and conditions associated with an unavoidable PUs, and 




Purpose Statement  
 The purpose of this project was to develop a clinical practice guideline (CPG) that 
would help nurses identify, describe, and document factors that influence the 
development of preventable (avoidable) and non-preventable (unavoidable) PUs. This 
CPG is expected to help differentiate between modifiable (extrinsic) and unmodifiable 
(intrinsic) risks factors associated with the development of preventable (avoidable) and 
non-preventable (unavoidable) PUs. The integration of evidence-based data will provide 
guidance to target high-risk populations pondering individualized unmodifiable (intrinsic) 
and modifiable (extrinsic) risk factors in order to reliably implement prevention strategies 
for all patients deemed at risk. The CPG components of an avoidable and unavoidable 
pressure ulcer will be considered in light of the state of the science and NPUAP 
consensus statements.                                                                                     
                                   Study Objectives 
 The objectives for this study were as follows: 
1. To give nurses guidance and to help them become competent in the 
identification, description, and documentation of modifiable and unmodifiable 
risk factors associated with PU development. 
2. To give nurses guidance and to help them become competent to differentiate 
in high-risk populations the factors that influence the development of 
avoidable (preventable) and unavoidable (non-preventable) PUs. 
3. To provide consistency and appropriate nursing documentation in 




4. To give nurses guidance and structure that support their decision process and 
knowledge they need to implement timely and appropriate prevention plans. 
Practice-Focused Questions 
1. What modifiable (extrinsic) and non-modifiable (intrinsic) risk factors are 
associated with pressure ulcer development?   
2. What modifiable (extrinsic) and non-modifiable risk factors (intrinsic) 
influence the development of avoidable versus unavoidable pressure ulcer 
development? 
3. Does the clinical practice guideline meet the validation criteria according to 
the expert panel review? 
4. Does the clinical practice guideline support the application of current 
evidence-based practice? 
Nature of the Project 
 This project sought to describe the development of a CPG to improve nursing 
practice that integrated evidence-based and empirical data to describe modifiable 
(extrinsic) and non-modifiable (intrinsic) risk factors in a patient's unique profile that are 
associated with the development of avoidable or unavoidable pressure ulcers. The CPG 
will incorporate the results of a literature review, combining expert consensus and 
scientific data to support the identification and description of modifiable and 
nonmodifiable PUs risk factors related to the development of avoidable versus 
unavoidable PUs. The CPG will be designed to appropriate identify and describe risk 




NPUAP’s conceptual definition and consensus. The clinical practice guidance criteria 
will follow a systemic review to define the inclusion and exclusion criteria of the 
modifiable and non-modifiable risk factors related to avoidable/unavoidable PUs, and 
then grade the strength of evidence.  
 To determine the content and criterion validity the Appraisal of Guidelines for 
Research & Evaluation II (AGREE II) instrument was used.  This instrument assesses the 
methodological rigor and transparency in which a guideline is developed. A 
multidisciplinary group of eight healthcare experts from academic and specialty areas 
were used, including two nurses educator/researcher (PhD), one nursing educator (MSN), 
one quality improvement nurse (RN), one physician (MD), one wound care specialist 
(certified nurses) and two nurse practitioner [FNP-BC]). The panel of experts were asked 
to rate the content for relevance, clarity, comprehensiveness, and appropriateness using a 
content validity survey. The use of domain scores made it possible to discuss whether the 
guideline should be recommended for use. The expert panel was e-mailed an informed 
consent prior to participating in the CPG revision. Experts were asked to review the CPG 
and return an evaluation and feedback within 2 weeks using a secure e-mail system. 
Results were integrated into a secured data base for analysis. IBM SPSS Statistics 21 
software was used to perform descriptive statistics and to evaluate the results. The 
approval I Walden’s Institutional Review Board was obtained prior to collecting data.                                                                                  





       Significance                                                                                                               
 A better understanding of the relationship between modifiable and nonmodifiable 
causative risk factors and the development of PUs can improve ability to identify patients 
at high risk and thus enable better targeting of resources in clinical practice (Coleman, 
2013). Appropriate identification and mitigation of risk factors can prevent or reduce the 
formation of PUs. In some instances, PUs are unavoidable because the magnitude and 
severity of risk are unmodifiable, or preventive measures are either contraindicated or 
inadequate due to the severity of risk (NPUAP, 2010). The scientific literature on PU risk 
factors and PU development identifies some risk factors and some circumstances in 
which the likelihood of an unavoidable PU could increase (Edsberg et al., 2014). 
Improving the process to capture the extrinsic and intrinsic factors is vital in order to 
improve the identification of patients who may develop unavoidable PUs. The WOCN 
Society (2017) position statement on avoidable versus unavoidable PUs recommended 
further research to evaluate which comorbidities and intrinsic factors are related to PU 
development to determine the clinical implications in the nursing practice. Additionally, 
it recommended that clinical documentation must include contraindications to preventive 
care in order to demonstrate rationale to determine unavoidable PU development 
(WOCN, 2017). 
 Over the last 16 years, the NPUAP has published various educational materials, 
white papers, and position statements on extensive collection of topics related to PU, but 
despite educational efforts from multiple organizations, the current research does not 




vulnerability for developing unavoidable PUs (NPUAP et al., 2014). It is time to integrate 
evidence-based knowledge that supports the nursing decision process to describe patient’ 
risk profile specifying modifiable and unmodifiable causes (Edsberg et al., 2014). From 
the perspective of real life practice, the literature shows gaps and limitations that affect 
clinical and organizational outcomes mostly due to lack of documentation obtained from 
the initial patient’s risk assessment and the need to properly describe patients at risk of 
developing unavoidable PUs. PU prevention involves a variety of aspects in the nursing 
process; and the content of nurses' reasoning when identifying the individualized 
patient’s risk factors is the first step in guiding the development of an accurate and 
measurable preventive care planning for nursing.  
 Evidence-based practices are centered on critical appraisals of effectiveness of 
care and the application of scientific data. The process of clinical decision making begins 
with the identification and description of risk factors that may be modifiable and 
unmodifiable. It is necessary that healthcare staff can identify the major characteristics, 
factors, and circumstances that influence the development of avoidable and unavoidable 
PUs. Further, it allows to make an accurate identification and documentation by 
implementing an evidence-based system to help define avoidable/unavoidable PUs. The 
identification of modifiable and unmodifiable risks factors will result in a best decision 
making when implementing clinical interventions. The NPUAP consensus statements 
(2014) understand that risk factors, monitoring, interventions, goals, and standards of 
practice are applied with the objective of preventing PU development consistent with a 





 Identification of the patient’s risk remains fundamental in the strategies of a PU-
prevention program. The identification of patient’s risks is more than defining a 
numerical score; it entails identifying those risk factors that contribute to the score and 
reducing the discrepancies by the applicability of the intensity and effectiveness of the 
strategies for the PU prevention (Kelechi, Arndt, & Dove, 2013). There are many factors 
and there is much complexity in the etiology, prevention, and management of PUs. The 
study of PU prevention is considered to be somewhat new, and that understanding is still 
evolving. It is well known that the etiology of PUs is a complex process in which 
multiple, often non-modifiable, intrinsic risk factors are associated, and which cannot 
entirely be measured by PU risk assessment tools (Berlowitz & Brienza, 2007; Edsberg et 
al., 2014; Lyder, 2003; RNAO, 2011). Currently, despite the great educational efforts 
from numerous entities, robust, scientific evidence that supports the identification of 
modifiable and unmodifiable patient risk factors is missing (NPUAP et al., 2014). 
Current investigations do not address the medical, multifactorial circumstances that may 
affect a patient’s risk and vulnerability for developing PUs (WOCN, 2009).                             
 For many years, multiple organizations developed and updated best practice 
guidelines or CPGs for the prevention and treatment of PUs. In 2003, the WOCN Society 
published a CPG for the prevention and management of PUs; it was updated in 2010 and 
2016 (WOCN, 2017). The objective of the CPG is to provide up-to-date, evidence-based 
recommendations to guide and support WOC nurses and other healthcare providers in the 




risk for PUs. In 2008, the WOCN Society published a guideline (updated in 2016) to help 
evaluate and document PUs in a variety of clinical settings 
(http://www.wocn.org/page/PUEvaluationCRG). But there were no evidence-based 
recommendations to guide in the identification and documentation of modifiable and 
unmodifiable PU risk factors.  
 The development of this CPG will add to the body of knowledge about factors 
that potentially contribute to the development of avoidable and unavoidable PUs by 
integrating patient characteristics and circumstances related to patient’s health status. 
Identifying the etiological factors and conditions associated to an avoidable and 
unavoidable pressure ulcer is necessary to ascertain the truth of best practices in pressure 
ulcers prevention. New screening methods as the use of a CPG will support nurses’ 
decision making and improve accurate interventions to high-risk populations. It is evident 
the need of a systematical approach that support nurses and other healthcare providers to 
associate and define the development of avoidable/unavoidable PU. Section 2 will 
evaluate evidence of the complexity of PUs etiology and the need to differentiate intrinsic 
and extrinsic risk factors associated to the development of avoidable and unavoidable 












Section 2: Background and Context 
    Introduction  
 PUs represent a significant problem in the healthcare settings. The development 
of PUs/PIs is considered the second most common reason for patients’ hospital 
readmissions. The costs vary from $20,000 to $70,000 per wound (Ducker, 2004). 
Accordingly, the costs related treating PUs/PIs complications during a single hospital 
stay transcend $200,000 per patient when PU/PI isn’t recognized on admission and 
complications progress from the PU/PI acquired (Brem, Maggi, Nierman, et al; 2010). 
CMS established that the average costs per hospital stay for a patient with a Stage 3 or 
Stage 4 PU/PI is $43,180 (Courtney, Ruppman & Coopers, 2006). The CMS also concur 
that 257,412 beneficiaries that are admitted to hospitals develop Stage 3 and Stage 4 
PU/PI, for a total CMS reimbursement to hospitals of over $11 billion (CMS, 2009). 
 In 2007, a randomized retrospective study analyzed 51,842 Medicare 
beneficiaries’ medical records from hospital discharges database for a 2-year period. The 
study showed that 5.8% of the patients had been admitted with PUs and 4.5% developed 
at least one new PU during hospitalization. Patients who developed HAPUs had a longer 
length of stay (4.8 versus 11.2), were more likely to die during the hospital stay (3.3% 
versus11.2%), were more susceptible to die within 30 days of discharge (4.4% 
versus15.3%) and were more probable to be readmitted within 30 days (17.6% versus 
22.6%) when compared with those patients who did not develop a HAPU (Moore, 2013). 
 In 2012, the costs for PU/PI treatment were estimated in U.K. considering 




Stage 2, the costs were estimated at $8,255; for Stage 3 the number was $14,240; and for 
Stage 4, it was $22,222 (Dealey, Posnett & Walker, 2012). In a study by Brem et al. 
(2010), the costs associated with treatment and secondary complications were calculated 
using a retrospective chart analysis. An evaluation of patients with Stage 4 PU was 
conducted during 29 months of follow up. Of 19 patients, 11 were classified as HAPUs 
and 8 were classified as Community Acquired PUs (CAPUs). Secondary complications 
comprised pain, depression, local infection, osteomyelitis, anemia, sepsis, gas gangrene, 
necrotizing fasciitis, and death. The average cost for Stage 4 HAPUs was calculated at 
$127,185 during one hospital stay and the average cost for Stage 4 CAPU was calculated 
at $124, 327 Healthcare providers must understand the clinical consequences of PUs in 
patients’ lives and the organizational implications related to costs and quality of care. 
This understanding should include evaluating prevention initiatives in order to develop 
quality improvement practices and best practices (Joint Commission Resource, 2012).  
 In 2001, The NPUAP reported the incidence of PUs fluctuating from 0.4–38% for 
hospitalized patients; 2.2–23% for long-term care; and as high as17% in home care 
(Bergstrom et al: 1992; Ayello, Frantz & Cuddigan, 2001). The cost of PUs must 
consider the cost of treatments, the costs to the patient and the family, and the costs to 
society which is affected by loss of time from work, as well as the potential cost of 
litigation and medical practice and more.  CMS recommends that nurses consider all risk 
factors independent of the scores obtained on any validated PU prediction scale. The 
foundation for the implementation of reliable and effective prevention guidelines requires 




interventions (Joint Commission Resource, 2012). Most of the revised PU prevention 
guidelines available on the National Guideline website are still based on risk factors 
identified over 20 years ago and these may not have the same significance today (RNAO, 
2005; American Medical Directors Association (AMDA), 2008). The development of a 
CPG that integrates current scientific data in defining factors associated with the 
development of avoidable versus unavoidable PUs will support nurses’ decision making 
and improve accurate interventions to high-risk populations.                                                                                                                 
Concepts, Model or Theories 
  The knowledge to action framework (KTAF; Graham et al., 2006) was chosen as 
the project’s conceptual framework. It describes and facilitates the proposed change in 
practice. The KTAF and its application to the project will be described. The KTAF aims 
to help researchers interested with knowledge translation deliver sustainable, evidence-
based interventions. The KTAF Knowledge to Action framework, established by Graham 
and colleagues (2000), makes it possible to systematically integrate new approaches to 
clinical practice. This framework builds on the structures from the assessment of 
planned-action theories that define in a systematic methodology interrelated concepts by 
which planned change occurs. The KTAF process is an iterative, dynamic, and complex 
process, related knowledge creation and the knowledge application (Graham et al., 2006). 
  The KTAF cycle details the sequence and steps involved in achieving the transfer 
of research knowledge into clinical practice consisting of two phases. The initial creation 
phases consist of synthesizing knowledge as part of producing new tools, such as clinical 




knowledge is obtained from best available evidence before to proceeding to the action 
phase, which include implementing and evaluating new knowledge in clinical practice 
(Graham et al., 2006). The action cycle includes seven phases: (a) identify the problem 
and relevant research; (b) adapt research to local context; (c) assess barriers to using the 
knowledge; (d) select, tailor and implement interventions; (e) monitor knowledge use; (f) 
evaluate outcomes; and (g) sustain knowledge use. 
  In KTA, process practice change consists of two concepts: knowledge creation 
and action. Inside KTA, knowledge is appreciated to be principally empirically derived 
(i.e., research based) but additionally incorporates other forms of knowing as experiential 
knowledge. The knowledge concept, denotes knowledge creation and comprises of the 
main types of knowledge or research, specifically, primary research, knowledge synthesis 
(e.g., meta-analysis), and knowledge tools and products (e.g., best-practice guidelines, 
decision-support tools; Graham et al. 2006).  
 (KTA by Graham et al. (2006) can also be used within broader frameworks as 
Outcomes-focused knowledge translation. The outcomes-focused knowledge translation 
was developed as a model to guide knowledge and it is also complementary to the KTA 
framework proposed by Graham et al. (2006). Outcomes-focused knowledge translation 
in this project we will utilizes third-generation knowledge, that is, practice guidelines 
integrated in decision-support tools that deliver research evidence in response to patient 
outcomes data. Therefore, it will incorporate two major sources of knowledge for 




to differentiate risk factors associated with the development of avoidable versus 
unavoidable PUs.  
 
Figure 1. Knowledge to action cycle, by Straus, S.E., Tetroe, J., Graham, I.D., 2013, 
Knowledge translation in health care: Moving from evidence to practice. p.10. Copyright 
1988 by Designs and Patents Act. Reprinted with permission. 
 
  The action part of the KTA process results in implementation or application of 
new knowledge. The development of a CPG will integrate the application of new 
knowledge to improve a better performance of care by providing a holistic approach that 
entails nurse’s guidance and competence to differentiate in high-risk population the 
factors that influence in the development of avoidable (preventable) and unavoidable 




translation is to provide the feedback to clinicians’ reference practice information, such 
as best-practice guidelines and feedback about change in the patient’s risk factors 
identification. In the Table 1.1 it is described each of the KTA phases and the process in 
the development of the CPG. The KTA process encompasses all the steps between the 
creation of a new knowledge and its application to produce beneficial outcomes for 
nursing care. 
Table 1 
Knowledge to Action Framework Phases in the Development of CPG 
Phases  
Identify problem Lack of a comprehensive approach that assist nurses to identify risk 
factors associated with avoidable versus unavoidable PUs. 
Adapt 
knowledge  
Synthetized scientific evidence to create a CPG that support 








Propose CPG adoption as a best practice by defining benefits of 
implementation to improve nursing practice and patient’s care.  
Monitor 
knowledge use 
Validate the essential components of accurate and appropriate use 
in the nursing practice.  
Evaluate 
outcomes 




U Promote the use of an evidence-based CPG in health care setting to 
adopt and expand nursing practice. Advance nursing activities to 
develop engagement to evaluate the impact on patients’ outcomes. 
 







Definition of Terms 
The defining terminologies for the CPG adaptation are the following: 
PUs definition and staging 
 The NPUAP redefined the term of PU as a pressure injury on 2016; they define 
pressure injury (PI) as: a localized damage to the skin and underlying soft tissue usually 
over a bony prominence or related to a medical or other device. The NPUAP (2016) state 
that the injury occurs as a result of intense and/or prolonged pressure or pressure in 
combination with shear. The tolerance of soft tissue for pressure and shear may also be 
affected by microclimate, nutrition, perfusion, co-morbidities and condition of the soft 
tissue (npuap.org, add page or paragraph number). The updated staging system includes 
the following definitions (NPUAP, 2016): 
1. Stage 1 Pressure Injury: Non-blanchable erythema of intact skin 
Intact skin with a localized area of non-blanchable erythema, which may 
appear differently in darkly pigmented skin. Presence of blanchable erythema 
or changes in sensation, temperature, or firmness may precede visual changes. 
Color changes do not include purple or maroon discoloration; these may 
indicate deep tissue pressure injury. 
2. Stage 2 Pressure Injury: Partial-thickness skin loss with exposed dermis 
Partial-thickness loss of skin with exposed dermis. The wound bed is viable, 
pink or red, moist, and may also present as an intact or ruptured serum-filled 
blister. Adipose (fat) is not visible and deeper tissues are not visible. 




commonly result from adverse microclimate and shear in the skin over the 
pelvis and shear in the heel.  
3. Stage 3 Pressure Injury: Full-thickness skin loss 
Full-thickness loss of skin, in which adipose (fat) is visible in the ulcer and 
granulation tissue and epibole (rolled wound edges) are often present. Slough 
and/or eschar may be visible. The depth of tissue damage varies by anatomical 
location; areas of significant adiposity can develop deep wounds. 
Undermining and tunneling may occur. Fascia, muscle, tendon, ligament, 
cartilage and/or bone are not exposed. If slough or eschar obscures the extent 
of tissue loss this is an Unstageable Pressure Injury. 
4. Stage 4 Pressure Injury: Full-thickness skin and tissue loss 
Full-thickness skin and tissue loss with exposed or directly palpable fascia, 
muscle, tendon, ligament, cartilage or bone in the ulcer. Slough and/or eschar 
may be visible. Epibole (rolled edges), undermining and/or tunneling often 
occur. Depth varies by anatomical location. If slough or eschar obscures the 
extent of tissue loss this is an Unstageable Pressure Injury. 
5. Unstageable Pressure Injury: Obscured full-thickness skin and tissue loss 
Full-thickness skin and tissue loss in which the extent of tissue damage within 
the ulcer cannot be confirmed because it is obscured by slough or eschar. If 
slough or eschar is removed, a Stage 3 or Stage 4 pressure injury will be 
revealed. Stable eschar (i.e. dry, adherent, intact without erythema or 




6. Deep Tissue Pressure Injury: Persistent non-blanchable deep red, 
maroon or purple discoloration. 
Intact or non-intact skin with localized area of persistent non-blanchable deep 
red, maroon, purple discoloration or epidermal separation revealing a dark 
wound bed or blood-filled blister. Pain and temperature change often precede 
skin color changes. Discoloration may appear differently in darkly pigmented 
skin. This injury results from intense and/or prolonged pressure and shear 
forces at the bone-muscle interface. The wound may evolve rapidly to reveal 
the actual extent of tissue injury or may resolve without tissue loss. If necrotic 
tissue, subcutaneous tissue, granulation tissue, fascia, muscle or other 
underlying structures are visible, this indicates a full thickness pressure injury 
(Unstageable, Stage 3 or Stage 4). Do not use DTPI to describe vascular, 
traumatic, neuropathic, or dermatologic conditions. 
An avoidable pressure ulcer (pressure injury) develops when the provider did not 
do one or more of the following: evaluate the individual’s clinical condition and 
pressure injury risk factors; define and implement interventions consistent with 
individual needs, individual goals, and recognized standards of practice; monitor 
and evaluate the impact of the interventions; or revise the interventions as 
appropriate (WOCN, 2009). 
An unavoidable pressure ulcer (pressure injury) develops even though the 
provider evaluated the individual’s clinical condition and PU risk factors; defined 




recognized standards of practice; monitored and evaluated the impact of the 
interventions; and revised the approaches as appropriate (WOCN, 2009). 
Holistic Care: The American Holistic Nursing Association (AHNA) describes a 
holistic nurse as one who takes a holistic (mind-body-spirit-emotion) approach to 
the practice of traditional nursing, an approach that is based on a body of 
knowledge, sophisticated skill sets, standards of practice, and a philosophy of 
living and being that is grounded in caring, relationship, and interconnectedness. 
(Kinchen, 2014). 
Hospital acquired PU: It is a complication, known as never event recognized by 
the Department of Health and Human Services as high-cost or high-volume 
events that could reasonably be prevented through the application of evidence-
based guidelines (CMS, 2008). 
Guideline or practice guideline are systematically developed statements to aid in 
the clinical decision-making of nurses and other healthcare professionals 
(National Institutes of Health, 1990). 
Risk factors are any attribute, characteristic or exposure of an individual that 
increases the likelihood of developing a disease or injury (World Health 
Organization, 2017, http://www.who.int/topics/risk_factors/en/  
Modifiable risk factors are those you can take measures to change them (UCSF 
Medical Center, 2017) 





    Relevance to Nursing Practice                                                                               
 A better understanding of the relation of contribution risk factors to the 
development of PU scan improve the ability to identify patients at high risk and would 
enable to better target resources in practice (Coleman, 2013). The integration of a CPG is 
critical to ensure identification of the high-risk population and target risk factors that 
influence in the development of avoidable and unavoidable PUs. Consistency in the 
nursing assessment, documentation and timeliness in the care plan interventions will 
improve the prevention efforts to minimize risk for PU development. More than 
providing specific guideline, and processes focused on expected outcomes; spell out on 
first use (EBP) give directions to nursing care interventions using the critical thinking 
process in the implementation and evaluation of patient care outcomes. EBP creates a 
view of nursing care as a framework for improving healthy environments and developing 
a vision of a systematic method for generating nursing interventions and care based on 
evidence (Omery & Williams, 1999). The incidence of avoidable PUs is recognized as an 
important quality indicator of care. The eradication of avoidable PUs is still a challenge 
and continues to denote an aggregate financial problem for healthcare system and to 
affect patients’ quality of life (Parnham, 2015). In most of cases, appropriate 
identification and mitigation of risk factors can prevent or minimize PU (injury) 
formation. However, some PUs are unavoidable (Edsberg et al., 2014). Criteria validation 
and further research related to accurate and applicable assessment and documentation for 
PU prevention and management (i.e., skin assessment, criteria of skin integrity, 




determine the role of validated instruments for assessment and documentation (Alvey, 
Hennen, & Heard, 2012; NPUAP et al., 2014; Pittman et al., 2016). No current evidence-
based guidelines on the topic is available that are suitable for use by nurses for the 
identification of modifiable and unmodifiable PU risk factors associated with PU 
development. New scientific research data is required to define a conceptual framework 
of PU risks and clarify the breach between the epidemiological, physiological and 
biomechanical evidence of the role of individual risk factors in PU development. This 
will enable the development of a PU standard method to apprise future risk factor 
research and the development of improved clinical guideline systems (Coleman, 2013).                                                    
    Local Background and Context                                                                                              
 In 2008, CMS released a regulation (Inpatient Prospective Payment System Final 
Rule, Fiscal Year 2010) that refused reimbursement for the care of selected hospital-
acquired conditions, which were denominated to be reasonably preventable (e.g., Stage 3 
and 4, HAPUs) through the application of evidence-based guidelines (CMS, 2008, 2009; 
Stokowski, 2010). Evidence-based guideline provides essential vision to clinicians and 
other stakeholders related the care interventions the patient received and their outcomes 
(i.e., assessment, prevention, treatment), and if a HAPU develops, denote that evidence-
based care was offered to support that the HAPU was unavoidable (Jacobson, Thompson, 
Halvorson, & Zeitler, 2016). Jacobson et al. (2016) reported that after implementation of 
a quality improvement initiative to improve documentation of evidence-based 
interventions to prevent PUs, a 67% reduction in HAPUs that were considered avoidable. 




2009, 2016) who has recognized that some PUs are unavoidable under 
evident circumstances, such as when the ulcers develop despite the provision of 
appropriate and accurate assessment and interventions. Consequently, for a PU to be 
considered unavoidable, there must be well-defined, a complete, and consistent 
documentation of the prevention and care interventions delivered to the patient is 
essential (Dahlstrom et al., 2011; Jacobson et al., 2016; Pittman et al., 2016; Worley, 
2007). 
 Patient acuity, medical technology, nursing hours at the bedside (Hall, Doran, & 
Pink, 2004; Kramer & Schmalenberg, 2005), nursing practice settings (Lake & Friese, 
2006), and PU risk factors identified in scientific research (Fogerty et al., 2008) have 
transformed in the past 20 years. Consequently, a new statistical analysis is essential in a 
predictive model, demonstrating possible interactions among currently identified risk 
factors and determining predictive contributions of each risk factor so that actions may be 
focused at risk factors that carry the greatest association with the development of PUs, 
particularly those factors that are modifiable.         
 Cowan (2015-2017) presented a summary of Fogerty et al. (2008) retrospective 
case-control study examining admission and discharge data from over six million patients 
in the Nationwide Inpatient Sample (NIS) to classify risk factors and demographic 
variances between those patients who developed PUs and those that did not. Their study 
can be defined as a nested case-control (Gordis, 2004) because they recognized a cohort 
(inpatients in the NIS dataset), trailed their records retrospectively considering hospital 




who developed PUs (cases) and those that did not (controls). There were 94,758 incident 
PUs reported including a final discharge sample of 6,610,787 persons. Using multivariate 
logistic regression analysis on 45 shared conditions identified in patients with PUs, they 
informed probabilities ratios (appraisal of comparative risk) for the most significant risk 
factors related with developing PUs. Investigation was also showed classifying the 
sample by age, race and gender. Age over 75 years was the more significant PU risk 
factor recognized with an Odds Ratio (OR) of 12.63 (meaning people over 75 years are 
nearly 13 times more probable to develop PUs than younger age groups). Other critical 
risk factors classified (registered in descending order) include: diagnosis of gangrene (OR 
10.94, 95% with a Confidence Interval (CI) of 10.43-11.48), septicemia (OR 9.78, 95% 
CI 9.33- 10.26), osteomyelitis (OR 9.38, 95% CI 8.81-9.99), nutritional deficiencies (OR 
9.18, 95% CI 8.81-9.99), pneumonitis (OR 8.70, 95% CI 8.33-9.09), urinary tract 
infection (OR 7.17, 95% CI 6.96-7.38), paralysis (OR 10.30, 95% CI 9.69-10.96), age 59 
to 75 years (OR 5.99, no CI reported), and African American race (OR 5.71, 95% CI 
5.35-6.10).                                                                                                                       
 Levine and Zulkowski (2015) performed a secondary analysis of PU statistics 
from two studies (Levinson, 2010, 2014), which were directed by the DHHS, Office of 
Inspector General (OIG) on adverse events among Medicare payees in acute care 
hospitals and Long-Term Care (LTC)/skilled nursing facilities (SNF). In the OIG studies, 
the concepts avoidable and unavoidable were not used. In its place, the OIG defined harm 
as preventable if it could have been avoided by better-quality assessment or alternative 




complications of the patient’s health condition or care that was required. Since the OIG 
did not use the terms avoidable or unavoidable, the researchers considered the terms 
preventable and not preventable substitutable with avoidable and unavoidable, 
respectively. In the OIG studies, a group of physicians defined the level of harm and 
determined the preventability/avoidability by implementing a decision algorithm that was 
specifically developed for the study of adverse events in hospitals. To determine 
preventability/avoidability, the OIG reviewers used medical records data, clinical 
expertise, literature research, and expert discussion. The OIG reviewers valued 
preventability integrating a 5-point scale (i.e., clearly preventable, likely preventable, 
likely not preventable, clearly not preventable, unable to determine). The incidence of PU 
in the hospitals was 2.9% and 3.4% in the LTC/SNF. Based on the OIG data, 39.1% of 
HAPUs and 40.9% of PUs in LTC/SNF were unavoidable leading Levine and Zulkowski 
to enquiry about the reliability and validity of PUs as a quality indicator with such a high 
rate of unavoidability. The researchers determined that while the structured 
algorithm/decision process used by the OIG to assess preventability was a strength of 
their studies, they did not identify any Stage 4, and only a few unstageable or Deep 
Tissue Injury consequently, their investigation might have undervalued the level of harm 
from facility-acquired PUs. Levine and Kulkowski suggested additional studies to 
establish validity and reliability for the algorithm.                                                                                                     
 Furthermore, relevant research provided in Fogerty et al., study it was described a 
statistically significant interaction between race and age, as it was found that African 




age, specifying notable racial disparities. In this study, some of the strongest risk factors 
are non-modifiable (age, paralysis, race) while others are potentially modifiable 
(infection, nutritional deficiencies). Consequently, research is needed to determine when 
interventions are most effective in those patients with non-modifiable risk factors (such 
as age > 75) or if interventions must be started in all persons over 75 years old. Research 
must also evaluate the most effective interventions to reduce or eliminate the identified 
modifiable risk factors (infection and nutritional deficiencies) and ways to accurately 
identify them in patients (Cowan, 2015-2017).                                                                                      
    Role of the DNP Student                                                       
 The literature demonstrates that there is a need to support clinician to identify 
patients at risk to the develop avoidable versus unavoidable PU improving clinical 
practice founded on current scientific evidence and accepted best practices. There is clear 
evidence of the need to integrate the latest evidence and scientific data in order to provide 
a holistic approach to identify complex risk factors in clinical situations that can be 
defined the patient risks factors associated with avoidable and unavoidable PUs 
development. The role as a DNP student encompass the use of the clinical expertise 
integrating the latest scientific data to generate practical solutions in nursing clinical 
practice through the application of an evidence-based guideline. The author is a nurse 
certified by the WOCNCB that will apply her clinical expertise and evidence-based skill 
set to improve practice trends adapting research data providing rationale feedback in the 
identification for avoidable/unavoidable PUs risk factors. The development of a CPG 




practice that support clinicians to interpret how modifiable and unmodifiable risk factors 
are associated with the development of avoidable and unavoidable PUs.  
 The DNP student recognize that for many years professional and organizational 
consensus have validated scientific data elucidating the how intrinsic factors and extrinsic 
risk factors can predispose patient to develops PU. But, currently there is no a single CPG 
that integrates and define patient’s risk associated with avoidable/unavoidable PUs 
development. From her extensive professional experience in the field of wound care, the 
DNP student considers that it is essential to innovate creating a CPG to improve nursing 
practice which can describe the multifactorial dimension of PU development to 
contribute improving clinical practice and patient quality care. The literature review 
establishes (NPUAP, 2017; WOCN Society, 2017) that unmodifiable factors associated 
with disease’s processes and comorbidities have a great effect in the PU development and 
as well the patients’ medical restrictions or inability to adhere to the preventive measures. 
These elements are crucial to be identify in the nursing assessment and clinical 
documentation process to clear distinguish the modifiable and unmodifiable factors 
associated with the patient’ risks to develop avoidable versus unavoidable PU. A well-
defined knowledge about PU multidimensional risks factors will help clinician to 
recognize patients at risk to develop avoidable/unavoidable PU by describing the 
influences of the patient’s unmodifiable (intrinsic factors) or patient’s clinical 
characteristic and unmodifiable (extrinsic) factors. Improved identification of patients’ 
risks will create accurate and realistic preventive clinical actions. Clinical guidelines 




consistency of care, and by creating derived implementation materials. Clinicians can use 
guidelines to make better decisions, initiate quality improvement efforts, prioritize new 
research initiatives, and support coverage or reimbursement for proper services 
(Rosenfeld & Shiffman, 2010). The development of this CPG will add to the body of 
knowledge about factors that potentially contribute to the development of avoidable and 
unavoidable PUs by integrating patient characteristics and circumstances related to 
patient’s health status. In addition to approaching the problem of lack of an evidence-
based guideline to identify and describe risk factors related avoidable/unavoidable PU 
development, this guideline will provide evidence that clinicians delivered her 
interventions considering patient’s characteristics and needs.                                                                                                                        
     Summary                                                                       
 For many patients, healthcare conditions generate complex factors of 
pathophysiologic processes; for which it results in the development of an unavoidable PU 
(Berlowitz & Brienza, 2007). The development of a PU is a multifactorial event that 
sometimes may not be prevented even with high quality multidisciplinary prevention and 
treatment strategies. Moreover, no single interventional strategy has been informed that 
consistently and reliably decreases PU incidence to zero (Thomas, 2003). Nevertheless, 
the goal of care is to do all interventions possible, given each individual’s unique intrinsic 
and extrinsic risk factors, to prevent the development of a PUs (Padula, Osborne & 
William, 2009).                                     
 The use of an evidence-based CPG will help to evaluate multifactorial patients’ 




tailored to the specific risk profile of each patient. PU care planning is a process by which 
the patient ‘s risk assessment information is translated into an action plan to address the 
identified patient needs. This synthesis of multiple types of patient data requires the 
clinician to take a holistic approach rather than just relying on one specific piece of 
patient information (AHRQ, 2014). Quality improvement initiatives in healthcare 
systems are required to identify the elements that are necessary for effectively 
implementing and sustaining evidence-based practices into patient’s care. The use of 
stratification guideline systems as accurate methods to identify and describe patient’s 
risks could help clinicians in the accurate recognition of risk factors for the development 
of avoidable/unavoidable PUs complications. The key role of assigning modifiable and 
unmodifiable risk category will be guiding management efforts and the benefits of a 
multidisciplinary team approach (Morey & Smith, 2015).  
 PU prevention involves a variety of aspects in the nursing process; and the 
content of nurses' reasoning when identifying the individualized patient’s risk factors is 
the first step in guiding the development of an accurate and measurable preventive care 
planning for nursing. Improvements in quality must be recognized that reduce practice 
variations and incidences of inappropriate care; providing criteria for monitoring the 
processes and outcomes of care. And most of all, the CPG, “Differentiating risks factors 
associated with the development of avoidable and unavoidable PUs,” will emphasize 
nursing appropriate and specific competencies in order they can make informed decisions 
using critical think when identify and describe patients at risk to develop preventable and 




 Section 3 will describe the method of collection and analysis of evidence for 
recommendations to support an innovative method to describe risk factors related to 
avoidable/unavoidable PU development. This study describes evidence-synthesis 
resources consistent with the strength of the recommendations to describe operational 





















Section 3: Collection and Analysis of Evidence 
Introduction 
When creating EBP, it is necessary to evaluate the effectiveness of an intervention 
or practice in order to translate science into clinical practice (McCaffrey, 2012). As a 
wound care expert, I incorporated the NPUAP consensus statements and literature review 
to define and list modifiable and non-modifiable risk factors associated with the 
development of avoidable versus unavoidable PUs. To develop the CPG, I incorporated a 
systematic approach to identify the scientific evidence for the criteria that the literature 
recognizes as modifiable and unmodifiable risk factors for PU development. To increase 
the possibility that significant empirical and scientific evidence was incorporated, I 
conducted a literature review using appropriate key words. It included systematic 
reviews, controlled trials, qualitative research, expert opinions, and consensus statements. 
National and international conferences findings, government web site information, and 
relevant federal and state guidelines, and as well as professional regulations in nursing 
practice, were included. To locate publications the following databases were used: 
PubMed.gov-US National Library of Medicine National Institute of Health, PsycINFO-
American Psychological Association, CINAHL database (Cumulative Index to Nursing & 
Allied Health Literature), MEDLINE/PubMed Resources Guide, Cochrane library, ERIC 
(Education Resources Information Center), TRIP database (Turning Research Into 
Practice) . Peer-reviewed articles published between 1970 and 2018 were examined. Key 
words will be selected so that all articles relevant to the d project and clinical guideline 




for PU development, modifiable and unmodifiable risks for PU development, avoidable or 
unavoidable PUs and factors lead to PU development.                                                                                                              
 The development of the clinical guideline involved the identification and 
validation of themes and topics stating the most relevant aspects of PU risk factors to be 
measured. I integrated the modifiable and non-modifiable risks to PU development based 
on the literature review using the Agency for Health Care Policy and Research’s 
(AHCPR) CPG (Panel for the Prediction and Prevention of PUs in Adults, 1992), WOCN 
Society Position Paper: Avoidable versus Unavoidable PU (2017), the Guideline of the 
National Institute for Health and Clinical Excellence (NICE, 2005), the Consensus and 
Statement of the European Pressure Ulcer Advisory Panel, and the National Pressure 
Ulcer Advisory Panel’s Unavoidable Pressure Injury: State of the Science and Consensus 
Outcomes (2014). The Appraisal of Guidelines for Research & Evaluation II instrument 
(AGREE II, 2013) was used to assess the experts’ agreement on the relevance of whether 
the guideline should be recommended for use. If in the opinion of the experts, a theme did 
not describe or evoke any relationship to the domain under study, it would be removed or 
amended.  
Based on this procedure, I assumed that the CPG covers the domains for the 
identification and definition of risk factors associated with avoidable/unavoidable PU. 
Based on the experts’ review, additional criteria were reviewed. This CPG was developed 
based on the most recent body of evidence, references provided from 1971 to 2018 was 
included to have a wide foundation of the risk factors elements. Additionally, expert 




the 2014 NPUAP Consensus Statement was considered. The CPG was designed to 
identify and describe the modifiable and unmodifiable risk factors associated with 
avoidable/unavoidable PU (see Appendix A). The CPG development followed a 
systematic method with inclusion and exclusion criteria to search the literature, and grade 
the strength of evidence (Moran, Burson, & Conrad, 2017). To compiling evidence and 
assessing evidence for quality it was used Fineout-Overholt, Melynk, Stillwell, and 
Williamson literature assessment for levels of evidence. The Appraisal of Guidelines 
Research and Evaluation (AGREE) II was used to provide the framework to assess the 
quality of the guideline developed. Using the AGREE II Instrument, the expert panel 
reviewed the guideline to validate content. A summary of findings in the wound expertise 
area was presented, along with references, generalizations, and conclusions obtained from 
review of the literature. In the conclusion, the state of knowledge and discussion of the 
strength of evidence was presented to support the selected problem, developing and 
contributing to the body of knowledge in the field of research (Gray, Grove & Sutherland, 
2017).  
 Content validity of the clinical guideline was established by an extensive 
literature review (Kelechi, Arndt, & Dove, 2017; Kallman & Lindgren, 2014); Roger, 
2013). This DNP study accomplished with ethics approval from Walden University IRB 
to assure all parameters compliance with university policies and federal regulations are 
met. After obtained IRB approval (number: 05-08-18-0457154), the content validity was 
obtained from the group of experts’ reviews. Potential members of the working group 




discipline, some participants were content experts for the guideline topic and other 
content expert of research and education. The selection panel included the participation 
of a multidisciplinary healthcare team (physician, nurses’ specialists in research, wound 
care, quality improvement and nurse educators). Experts’ panel were familiar in the 
wound care practice, had prior experience with evidence-based guideline development, 
and demonstrated skills with using the internet, e-mail, and e-mail attachments. 
Anonymous questionnaires were used to conduct paper and online surveys of experts’ 
panelist. The expert panel was e-mailed an informed consent prior to participate in this 
revision. 
 The panel of experts were asked to rate the content for relevance, clarity, 
comprehensiveness, and appropriateness using a content validity survey. The use of 
domain scores was used to discuss whether the guideline should be recommended for use. 
Experts were asked to review the CPG and return evaluation and feedback using secured 
e-mail system. The timeframe given to experts to provide feedback was two weeks. 
Results were integrated in a secured data base to be analyzed. IBM SPSS Statistics 21 
software was used to perform descriptive statistics and evaluate results obtained. 
Electronic communication was convened to provide feedback throughout the CPG 
evaluation and before the publication plan. Conference calls were convened as needed 
during the evaluation process. After the content of the CPG was validated, the final 






Sources of Evidence 
PUs description in clinical literature dated from the 1500s when Fabricius 
Hildanus first documented his hypotheses of the causes and characteristics of bedsores. 
He emphasized the role of "internal supernatural" and "external natural" factors that 
disturb the supply of blood and nutrients to tissue as triggers of bedsores. French surgeon 
de la Motte in 1722 considered that mechanical pressure and incontinence were main 
factors in the development of PUs by (Defloor, 1999). Main risk factors identified for PU 
development in the scientific literature later 1987 include increased age, impaired 
mobility, declined physical activity, poor nutrition, urinary and/or fecal incontinence, and 
sensory impairment (Allman, 1997; Ayello & Lyder, 2001; Reddy, Gill, & Rochon, 
2006). Other studies have identified additional risk factors including smoking status, 
diabetes mellitus, coronary artery disease, intensive care unit stay greater than 3 days, 
ventilator dependency, pneumonia, sepsis, obesity, surgery, female gender, and peripheral 
vascular disease (Berlowitz et al., 2001; de Souza, & Santos, 2007; Cowan et al., 2012). 
Most PUs are considered to be avoidable, therefore, preventable (Jalali & Rezaie, 2005; 
Bryant & Nix, 2007; NPUAP, 2009). Understanding the complexity in the clinical setting 
in which healthcare environment strive with the complications of patients’ diseases and 
comorbidities, create conclusions that not all PUs are avoidable or preventable.  The 
skin is the largest organ of the body; and its integrity is affected by multiple factors as 
patient’s age, medications, microclimate, optimal functioning of other organs, and 
concomitant diseases/illnesses. The development of PUs is impacted by various risk 




developed to reduce the incidence of PUs, the expectance of achieving a zero-incidence 
rate may not be a realistic target (Edsberg, Langemo, Baharestani, Posthauer, & 
Goldberg, 2014).   
 CMS has been part of economic, social, and political propositions on research 
findings regarding PU risk and coverage services. In recent symposium of the 
International Expert Wound Care Advisory Panel called, "Opportunities to Improve PU 
Prevention and Treatment: Implications of the CMS Acute Care Present on Admission 
(POA) Indicators/Hospital-Acquired Conditions (HAC) Ruling" (February 2008) 
highlights one PU specific ramification of Deficit Reduction Act of 2005. The expert 
panel stated successive changes in the Centers for Medicare and Medicaid Services 
(CMS) financial reimbursement amounts for nursing homes and hospitals. Beginning in 
October 2008, CMS will no longer reimburse higher rates for patients that develop Stage 
3 or 4 PUs/PI (full-thickness tissue loss) after admission (Armstrong et al., 2008). This 
represents a potential risk for economic loss to health care providers. This is supposed to 
add motivation to acute and long-term care facilities to evaluate and improve their 
documentation and PU prevention programs. This symposium is significant, as it 
emphases the urgency of a consensus among health care providers and particularly the 
wound care community in providing quality research and evidence-based (and 
innovative) interventions that are effective.   
 The NHS Institute for Innovation and Improvement (2009) understand that 
sustainable change in PU prevention requires a strong strategy integrating well-defined 




important performance indicator of quality care (Fletcher 2014; Stephen-Haynes 2014). 
For quality improvement, such indicators must be reinforced by evidence-based standards 
of care. Mainz (2003) stated that clinical indicators should relate to structure, procedure 
and result. However, the structure partly implies the service within the organizational 
structure, the procedure or process represents the guidelines of the care delivery related to 
PU prevention, and the result specifies the achievement of that clinical practice related to 
the exclusion of avoidable PUs development. The need for strategies and standards for 
practice encompasses the creation and implementation of new documentation to 
incorporate multidimensional risk identification and prevention (Parnham, 2015).                                                                                                                                                                              
     Summary                                                                
 The literature establish that more research is needed to develop risk-adjusted 
models to establish which particular risk factors or combination(s) of risks are principal 
predictors of PU development to enhance the efficiency/effectiveness of risk assessment 
and define PUs that are unavoidable (Anderson et al., 2015; Levine et al., 2009). 
Pressure-ulcer prevention remains an inexact science. Recent international guidelines 
highlight the lack of robust, high-quality research to guide practice. The only Level 1 
evidence available relates to repositioning and use of nutritional supplements (EAP & 
NPUAP, 2009). Strategies such as the use of PU clinical screening guidelines for 
preventing PUs have a limited evidence base, and this is an area where much more work 
is needed (Webster, 2011). Data obtained from this project will be used to inform an 
innovative method to describe risk factors related to avoidable/unavoidable PU 




define key prevention strategies and provide clinicians with a clear, standardized 
approach to risk assessment.                                                                 
 The main element of PU risk is strongly associated with the general health status 
and severity of illness contained in the patient’s intrinsic factors. Experts agree 
documentation provides fundamental feedback to clinicians and other key participants 
regarding the interventions the patient received and their effects (i.e., assessment, 
prevention, treatments), and if a HAPU is develop; it is necessary to provide verification 
that evidence-based care was delivered to support that the HAPU was unavoidable 
(Jacobson, Thompson, Halvorson, & Zeitler, 2016). Recent findings state that is 
reasonable to question the correlation that exists on the no modifiable patient-related 
factors and the development of unavoidable PUs (even thus receiving evidence-based 
prevention and treatment strategies (Hagisawa & Barbenel, 1999).                                                         
 No modifiable PU risk factors can be behavioral, medical treatment related, 
and/or physiologic. Some examples of no modifiable risk factors include, (a) patient 
cognitive impairment that create inability to decrease pressure on areas at risk related to 
noncompliance, refusal, or neurologic impairment; (b) treatments resulting in poor tissue 
perfusion and fluid retention, (c) hemodynamic instability resulting in an inability to turn 
and/or reposition, respiratory instability, unstable spine; (d) diseases that affect tissue 
tolerance and response to nutrition, arterial insufficiency, and arterial emboli; and (e) 
inability to use pressure redistribution devices associated with other pre-existing 




nursing care. The literature and scientific findings have been implemented to identify 
factors related to PU development (Bostrom & Kenneth, 1992).  
 This project sought to describe the development of a CPG to improve nursing 
practice that integrated evidence-based and empirical data to describe modifiable 
(extrinsic) and non-modifiable (intrinsic) risk factors in a patient's unique profile that are 
associated with the development of avoidable or unavoidable PUs. This is the first CPG 
that systematically evaluate the quality of description of intrinsic and extrinsic risk 
factors to define avoidable or unavoidable PU development. Precise identification of 
intrinsic and extrinsic PU predictors will help define key prevention strategies and 
provide clinicians with a clear, standardized approach to risk factors assessment. This 
study provides relevant and new comprehension sustaining recommendations in the 
identification of avoidable and unavoidable PUs risk factors. Inputs of this study describe 
evidence-synthesis resources consistent with the strength of the recommendations to 
describe operational criteria when assess risk factors associated with avoidable and 
unavoidable PU development. 
 Section 4 will present inputs of the evaluation of the CPG and will describe 
strength of the recommendations appraised when assess risk factors associated with 
avoidable and unavoidable PU development. Expert panel members agreed that the CPG 
will provide guidance and competence in the identification, description and 
documentation of modifiable and unmodifiable risk factors associated with PUs 




influence in the development of avoidable (preventable) and unavoidable (non-




   Section 4: Discussion and Implications 
Introduction  
 
 Quality of nursing practice encompasses numerous components, including 
maintaining the integrity of patients’ skin (Meraviglia, Becker, Grobe, & King, 2002). 
Therefore, CMS established that PU was considered a hospital-acquired condition and 
was no longer covered (Armstrong et al., 2008; CMS, 2006). In 2009, the CMS defined 
PUs (injuries) as reasonably preventable and discontinued reimbursement for the 
treatment of HAPUs, Stages 2 to 4 except when? these PUs were present at admission or 
developed within 2 days after admission. Nevertheless, clinicians state that some PUs 
(injuries) are unavoidable and will develop even when all preventive care interventions 
are applied. Examples of these circumstances are patients’ hemodynamic instability 
which requires pharmacologic or mechanical assistance to reduce perfusion; severe 
protein-energy malnutrition which affects skin tolerance, and skin impairment in patients 
at the end of life (Black et al., 2011).  
 Precise identification of intrinsic and extrinsic PU predictors will help define key 
prevention strategies and provide clinicians with a clear, standardized approach to assess 
multifactorial risk factors associated to PU development. Nevertheless, it is critical to 
recognize that some PUs are inevitable. Recognizing the significance of this matter and 
the stated lack of information on PU unavoidability, the NPUAP held a scientific and 
professional multisector conference in 2014 to investigate the issue of PU unavoidability 
using a systematic structure, which contemplated the complexity of non-modifiable 




was written to synthetize the state of the science in the area of unavoidable PU evolution. 
An interactive consensus was obtained, based on these elements, including participants in 
various associations and organizations. Consensus was obtained when 80% agreement 
was reached. The participants agreed that unavoidable PUs do happen. Unanimity was 
also found in areas associated with cardiopulmonary and hemodynamic status, effect of 
head-of-bed elevation, septic shock, body edema, burns, immobility, medical devices, 
spinal cord injury, terminal illness, and nutrition (Edsberg et al., 2014).  
 The NPUAP has guided the two international consensus conferences on PU 
avoidability-unavoidability. The first conference in 2010 stated consensus on the 
presence of some particular circumstances when PUs can occur and be considered 
unavoidable. Given the extensive examination of the literature on PU risk factors and PU 
development, in the 2014 conference consensus was established on some risk factors that, 
in some selected situations, have been demonstrated to increase the probability of an 
unavoidable PU. The effort from these revolutionary conferences continues to define 
more of the conditions related to unavoidable PU occurrence. Coleman (2013), stated that 
new scientific evidence is necessary to elaborate a conceptual framework of PU (injury) 
risks and to elucidate the gaps between the epidemiological, physiological, and 
biomechanical evidence of the risk factor interaction in PU development. These actions 
will support the foundation of a PU standard system to describe potential risk factors to 
create improved risk assessment systems (Coleman, 2013).  





Findings and Implications 
 This is the first CPG that systematically evaluate the quality of description of 
intrinsic and extrinsic risk factors to define avoidable or unavoidable pressure ulcer 
(pressure injuries) development. This study provides relevant and new comprehension 
sustaining recommendations in the identification of avoidable and unavoidable PUs risk 
factors. Inputs of this study describe evidence-synthesis resources consistent with the 
strength of the recommendations to describe operational criteria when assess risk factors 
associated with avoidable and unavoidable PU development. Relevant systematic review 
of evidence was used to validate patient intrinsic and extrinsic risk factors associated with 
avoidable and unavoidable PU development. The comprehensive examination resulted in 
approximately 77 articles that included published articles and 2 expert consensus 
reviews. The inclusion and exclusion criteria were applied to improve the results. A 
checklist of 40 elements where categorized under the intrinsic and extrinsic PU risk 
factors. Scientific data and combination of recommendations developed by expert 
external organizations as Centers for Medicare and Medicaid Services (CMS), The Joint 
Commission (JACHO), the Wound Ostomy Continence Nurse (WOCN) Society, and the 
National PU Advisory Panel (NPUAP) were considered.  
 The CPG, Differentiating risk factors associated with the development of 
avoidable and unavoidable pressure ulcers (pressure injuries), is an evidence-based tool 
that is recommended to be used to assess, identify and differentiate the patient’s intrinsic 
and extrinsic risk factors related to the development of avoidable and unavoidable PU. 




underlying health condition or other factors that make a patient more vulnerable to 
develop PUs (The Joint Commission Resources, 2012). These factors include: the length 
of stay of the hospitalization, age, diseases and contributing factors, history of previous 
PUs, use of high risk medications, certain treatment or medical procedures, mental status, 
cultural and or religious beliefs conflicting with patient treatment; (2)- Extrinsic risk 
factors related to immediate environment that place patient at risk for developing PUs 
(The Joint Commission Resources, 2012). These factors include: nutritional deficiencies, 
impaired mobility, head of bed elevation, pressure, friction, shearing, moisture and 
patient habits. For the extrinsic risk factors, it is recommended to describe if these risks 
can be modifiable or unmodifiable upon patient’s health condition and treatment 
restrictions. 
 To identify CPG key development components the author used a standardized 
reference table to collect information and assist with preparation of tables of evidence 
ranking for each article in terms of the level of evidence, quality of evidence, and level of 
recommendations to practice. Clinical findings and levels of recommendations regarding 
the CPG risk factors were made by integrating critical analysis following a systematic 
review. A multilevel, systematic review approach was taken to identify and synthesize 
the literature that meets the eligibility criteria to build an evidence-based scientific data 
related to pressure ulcers intrinsic and extrinsic risk factors. To compiling evidence and 
assessing evidence for quality it was used Melnyk and Fineout-Overholt literature 




A: High, Level B: Moderate, and Level C: Weak and Not recommended for practice. 
Please see Levels of recommendations for Practice. 
 The GPG was validated by a group of experts in the healthcare sector, education 
and research. The selection for expert panel was composed of 8 participants (1 physician, 
two PhD nurses practicing in the nursing academic setting, one BSN wound care nurse 
specialist (WOCN) practicing in acute care, one DNP and one MSN both Nurse 
Practitioners practicing in long term care, one MSN quality improvement nurse and one 
MSN nurse educator both practicing in long term care setting). Experts were asked to 
provide their responses anonymously, to help reduce bias and any sort of pressure to 
respond a certain way. The panel experts rated the CPG content for relevance, clarity, 
comprehensiveness, and appropriateness using the Appraisal of Guidelines for Research 
& Evaluation II instrument (AGREE II, 2013). AGREE was used to assess the experts’ 
agreement on the relevance to facilitate the ability to implement the instrument with 
confidence. AGREE II contains six domains with a total of 23 items, each scored 1–7 
(Strongly Disagree through to Strongly Agree). The six domains include: Domain 1: 
Scope and purpose, Domain 2: Stakeholder involvement, Domain 3: Rigor of 
development, Domain 4: Clarity of presentation, and Domain 5: Applicability. Domain 
scores were calculated by summing up all the scores of the individual items in a domain 
and by scaling the total as a percentage of the maximum possible score for that domain. 
Maximum possible score = 7 (strongly agree) x # (items) x # (appraisers)  





The scaled domain score was calculated using the following formula: 
Obtained score – Minimum possible score 
Maximum possible score – Minimum possible score 
 
 The use of domain scores was applied to discuss whether the guideline should be 
recommended for use. Members of the expert panel independently completed the review 
of the CPG using AGREII tool and complete separate recommendations. The expert 
panel identified and assigned scores using the rating elements of AGREE II for quality 
and strength of evidence, and describes conclusions based on the review of the body of 
evidence. Expert reviewed the evidence-appraisal tables for each risk factors, the level of 
recommendations and then analyzed implications for practice. After comprehensive 
evaluation of the CPG healthcare expert panel expressed analysis for the methodology 
using AGREE II. The recommendations were appraised based on supporting evidence. 
The general quality of the CPGs was high; the domains that showed the highest scores 
were: scope and purpose 100%, applicability 100%, editorial independence 100%, rigor 
of development 99.7%, clarity of presentation 99.3%, while the stakeholder involvement 
domain showed the lowest scores 94.4%. (See Appendix C. Experts Panel Rating CPG 
domains using AGREE II criteria). The experts panel agreed that this guideline maintains 
the evidence grade assigned, and they recommend this guideline for use. Expert panel 
members agreed that the CPG can be adopted as a new clinical practice complementary 
to nursing assessment in acute or long-term healthcare settings. They all also concurred 
that the integration of both, intrinsic and extrinsic risk factors independently of the level 
of the recommendation creates a well-known multifactorial patient risk profile sustain 




 Experts coincided that the origin of the unavoidable PU encompass systemic and 
environmental multifactorial events that predisposed patient’s skin to be more vulnerable 
under specific circumstances. Expert recommend the use of the CPG as part of a 
comprehensive PU prevention program as a strategy to produce consistency in the 
documentation of the patient risk categorization integrating intrinsic and extrinsic risk 
factors, and by representing individualized care interventions and measuring outcomes 
along with the patient health status progression. They understand that the CPG helps 
differentiate risk factors that are not contemplated on available assessment tools. This 
allows for the planning of care centered on patients’ specifics. Experts understand that the 
CPG is clear and concise. They highlighted that interpretation of the patient risk factors 
can change when patient health condition change requiring reapplication of the CPG. 
Their feedback and comments were provided. The guideline entails individuals as a 
whole considering patient’s preferences, cultural values and beliefs which can inhibit 
patients to receives PU preventive interventions. Identify risk population and their 
contributing factors associated with avoidable and unavoidable PU etiology provide a 
comprehensive visualization that will support nurse preventive interventions. As 
interpretation rely on nurses’ skills and knowledge to understand the complex interaction 
of the intrinsic and extrinsic patient risk factors, an educational plan is essential. 
Maintaining skin integrity is a long-standing theme in the scientific literature and most 
nursing textbooks. However, the approach and rigor for developing these guidelines will 




 At the final stage of the CGP evaluation a group of 9 registered nurses were 
incorporated to discuss the revised guideline to validate content and ensure 
usability. During the discussion 80% of the nurses understand that the CPG must be 
applied before performing any validated risk assessment tool. They state that the use of 
the CPG provides a comprehensive risk factors visualization and evaluation that will help 
to perform more precise the validated risk assessment tool they have in use. They 
considered that the application of the CPG will help nurses to be more conscious of the 
intrinsic risk factors that are missing in the validated PU risk factors tool. This analysis 
will provide to understand how patient’s health conditions (intrinsic factors) directly 
impact the extrinsic risk factors conditions in PU development. The nurses indicated that 
more than visualize a numeric scale (using a validated risk assessment tool) the CPG 
provides a comprehensive screening bringing significance of what the scale’ s numbers 
really mean in the patient illness process. They discussed that the CPG creates best 
practices promoting a culture of safety and quality of care. They consider that preventive 
interventions require a holistic perspective based on patient individualized needs and 
upon patient’ health status. The only concern that the group expressed during the 
discussion of the CPG was the implementation process in the clinical setting. Some 
expressed that it would take more time to perform the patient risk assessment and this 
will require from management to be involved and support this practice change. Also, they 
expressed that educational activities will be required in order that nurses can wisely 
understand how each risk factors categories contribute to the development of avoidable 




Overall Guideline Assessment 
 
 Expert panel and end user members understand that nursing practice 
transformation is necessary, and the integration of a comprehensive evaluation of 
intrinsic and extrinsic risk factors in the PU prevention is needed to improve clinical 
outcomes. Create a new method to ensure identification of the high-risk population and 
target risk factors that influence in the development of avoidable and unavoidable PU 
represent a change in practice. The use of the CPG will provide guidance and competence 
in the identification, description and documentation of modifiable and unmodifiable risk 
factors associated with PUs development and will assist to differentiate in high-risk 
population the factors that influence in the development of avoidable (preventable) and 
unavoidable (non-preventable) pressure ulcers. This will offer consistency and 
appropriate nursing documentation in circumstances when a PU is identified as 
unavoidable. The CPG structure will support nurses’ decision process and knowledge 
needed to implement timely and appropriate prevention plan. 
 This CPG (CPG) was recommended to be applied in conjunction with a validated 
PU risk assessment to categorize the patient risk factors associated with develop 
avoidable versus unavoidable pressure ulcers. This, will support to implement effective, 
realistic and individualized preventive measures along with the continuous of the 
patient’s illness evolution. It is recommended to implement the CPG in acute and long-
term care setting in vulnerable population with chronic conditions and comorbidities 
(Grade B), especially those critical ill and in patient with terminal conditions (Grade A), 




(Level B), cognitive status (Level C), nutrition (Level B) and can impair cardiac and/or 
respiratory status (Level A) leading to the PU development. 
The recommendations are to develop reliable processes assuring consistent 
implementation of an evidence-based CPG in care settings to address nursing decision 
making trough the assessment of vulnerable population. It is recommended to implement 
the CPG as part of a comprehensive PU preventive program and as quality improvement 
project to evaluate the effect of clinical interventions and patients’ outcomes. The use of 
the CPG can be implemented before or after the use of a validated PU risk assessment 
tool. The use of the CPG can support accurately risk factors documentation and 
interventions when preventive clinical measures are contraindicated. 
 Healthcare conditions create complex factors of pathophysiologic processes in 
vulnerable population; for which it result in the development of an unavoidable PU 
(Berlowitz & Brienza, 2007). The development of a PU is a multifactorial event that 
sometimes may not be prevented even with high quality multidisciplinary prevention and 
treatment strategies. Moreover, no single interventional strategy has been informed that 
consistently and reliably decreases PU incidence to zero (Thomas, 2003). Nevertheless, 
the goal of care is to do all that is possible, given each individual’s unique intrinsic and 
extrinsic risk factors, to prevent the development of a pressure ulcer/injury (Edsberg et 
al., 2014).                                     
 The use of an evidence-based CPG will help to evaluate patients’ risks. Some 
parts of PU prevention care are highly routinized, but care must also be tailored to the 




risk assessment information is translated into an action plan to address the identified 
patient needs. This synthesis of multiple types of patient data requires the clinician to 
take a holistic approach rather than just relying on one specific piece of patient 
information (AHRQ, 2014). Quality improvement initiatives in healthcare systems are 
required to identify the elements that are necessary for effectively implementing and 
sustaining evidence-based practices into patient’s care. The use of CPG as an accurate 
method to identify patients intrinsic and extrinsic risk could help nurses in the accurate 
recognition of risk factors for the development of PUs complications. The key role of 
defining patients a risk factors category will be guiding management efforts and the 
benefits of a multidisciplinary team approach (Morey & Smith, 2015).            
Recommendations 
This CPG recognizes nursing assessment as a continuous process in the clinical 
practice. The use of this CPG will assist nursing to screen high-risk population taking in 
consideration the risk factors associated with the development of avoidable or 
unavoidable pressure ulcers. This guideline will offer a structure to identify and 
differentiate multifactorial intrinsic and extrinsic patient risk factors associated with the 
patient health profile. This CPG intend to provide structure that support nurses’ decision 
process and knowledge needed to implement timely and appropriate prevention plan and 
ensure consistency documentation in circumstances when PU development must be 
classify as an unavoidable event. The use of a CPG must be recognized that reduce 
practice variations and incidences of inappropriate care; providing criteria for evaluating 




contribute in clinical practice and patient decisions about applicable health care for 
specific clinical circumstances (Woolf et al., 1999). The key role of identify risk 
categories in PU development will guide clinical management efforts and quality 
improvement strategies creating and sustaining changes at the institutional and policy 
levels.                                                                                    
The new CPG will assist to redefine population at risk to develop unavoidable PU 
and reconsider the inclusion of acute, intensive care and palliative vulnerable high-risk 
care settings. New scientific data obtained from this CPG will support the evaluation of 
current local and national policies and regulations related quality clinical indicators 
considering the probability of unavoidable PU development in other care setting from 
long term care. Clinical documentation obtained from the CPG will demonstrate the need 
for revision of local and national reimbursement policies when organizations manage 
complex risk processes and when special care interventions are required for PU 
prevention. Furthermore, the use of the CPG (CPG): Differentiating risk factors 
associated with the development of avoidable and unavoidable pressure ulcers (pressure 
injuries) can produce an important function in health policy formation and could change 
the PU prevention strategies across the health care continuum. Data from this project may 
be used to inform a new assessment method, which would innovate nursing clinical 
practice. It is critical to comprehend the need to integrate new research on PU risk 
assessment to predicts not only if the patient will develop a PU but, it also if this PU can 





  Strengths and Limitations of the Project                                                                      
 This study had several strengths, the author of the CPG is an expert matter in 
wound care who integrated her expertise and clinical skills in the use of the scientific 
evidence incorporating intrinsic and extrinsic risk factors that define patient risk profile 
associated with the development of preventable or not preventable PU. The experts’ 
panel included expertise and interdisciplinary composition including healthcare 
professionals, direct patient care nurses, wound care expertise, educators and researchers. 
These experts were crucial in the review of the CPG to evaluate the impact from a 
multifactorial scenarios and foresight a new perspective in the clinical practice. The study 
provides an innovative tool that provides a new perspective of analysis and interpretation 
of how the patient’s health status and preferences can impact risk factors associated with 
preventable and not preventable PU. It is the first time that an evidence-based screening 
tool integrates and define intrinsic and extrinsic risks factors associated with avoidable or 
unavoidable PU development. Qualities of CPG, includes ease of use, clear systematic 
basis, and strong association among research and level of recommendations. However, 
further research is needed to aim in whether the use of CPG makes any difference to 
provide effective interventions based on risk factors categorization. Future research 
should ensure that the use of a CPG can provide to evaluate how multifactorial extrinsic 
and intrinsic risks factors can help to clinically define patient risk profile supporting 
definition of avoidable versus unavoidable PUs. 
The author anticipated that the lack of previous evidence consistent with the CPG 




avoidable and unavoidable PU limits interpretation and overall conclusions. This GPG 
has not been tested before to determine strength and limitation in clinical practice. 
Practical utility of the CPG instrument was defined by the experts’ panel 
recommendations and convenience in use but not testing on predictive performance. The 
small number of experts’ panel participation in the review of the CPG limits 
generalizability of the findings and recommendations. The summative evaluation method 
used in this project limit to accurately interpret the multifactorial risks factors correlations 
to inform future implementation efforts. Multivariable estimation methods were not 
applied to define the quantitative impact of risk factors associated with avoidable and 
unavoidable PU development. There is a need to conduct further research directed to 
evaluate among high-risk groups and whether conduct the CPG help to accurate define 
avoidable and unavoidable PU.  
In Section 5, I will discuss the translation of new knowledge to produce change in 
practice, and the way that the CPG will be disseminated throughout the wound care 
sector, policy makers, organizations and clinicians to prove and implement the findings 










   Section 5: Dissemination Plan 
 The development of the CPG brings me the opportunity to publish important 
evidence in the wound care sector. A new methodology to evaluate individualized risks 
factors associated with the development of avoidable versus unavoidable PU requires that 
nurses create a holistic approach when identify patient’s risk factors. This CPG can be 
published in a wound care professional journal contributing to the discussion of new 
scientific knowledge and knowledge translation when defining vulnerable population and 
risk to develop avoidable or unavoidable PU. This opportunity provides me sharing 
knowledge through an innovative methodology to improve nursing practice, quality of 
care and a safe culture. The translation of new knowledge to produce change in practice 
benefit to congregate policy makers, organizations and clinicians to prove and implement 
the findings of my project. Additional value of this study comprise help to promote other 
research-related activities by health professionals where there are gaps in knowledge and 
innovation. Nurses will be the primary audience to share the project findings promoting 
new improvement strategies to advanced levels of clinical judgment, systems thinking, 
delivering, and evaluating evidence-based care to improve patient outcomes (AACN, 
2006). Translating outcome data is essential in the redesign of healthcare systems, 
organizational policies, and change in procedures. At the end, evidence-based practice is 









Analysis of Self 
 
 The journey of my DNP project enhanced my leadership competencies to advance 
my role of specialty. The develop of a CPG helped me to reflect on a new clinical 
practice model that proposed proficient nursing practice based on evidence. The 
integration of my clinical competences and the use of scientific groundwork created the 
correct route to initiate the process to reach a new vision to develop a change in nursing 
practice. The use of evidence-based practice in wound care practice supporting the 
desired change of improvement in patients’ quality of life, clinical outcomes, satisfaction 
and cost-effectiveness were integrated as the foundation of the reason to develop the 
CPG. During this process I had the opportunity enhance my nursing advanced role 
applying theories models and research to appropriate delineate my project journey. 
Understand how theory, research, and evidence-based practice can guide a change in 
practice contributed to integrate nursing knowledge translation in to an evidence-based 
CPG. The evaluation of theoretical literature and empirical data positively influenced to 
define my project development. New skills in leading change through the translation and 
application of evidence in clinical practice were obtaining during this process. The CPG 
developed creates strategies that provides strong emphasis on care quality to persuade in 
the importance to integrate intrinsic and extrinsic risk factors to target risk population 
vulnerable to develop avoidable and unavoidable PU. 
  The development of the evidence-based CPG to evaluate the effectiveness of 
nursing interventions will improve clinical practice and patient outcomes. Having the 




delivery approaches that meet the current needs of vulnerable populations, helped me to 
obtain the expertise to understand the processes which positive changes can provide to 
better outcomes. A new approach of nursing assessment considering the use of the CPG 
including the non-modifiable and modifiable patient’s risk factors fulfil not only with the 
standard of care in nursing, but also with the important goal and concept of the patient-
centered care. The fact of identify the non-modifiable and modifiable risk factors in the 
patient profile is a central component to help nurses determining avoidable versus 
unavoidable PUs development and validate best practices to decrease the incidence of 
avoidable PUs. Nursing science can be transformed through the use of evidence-based 
practice. This learning experience built on my advanced nursing practice specialization 
provided additional preparation in the formulation, interpretation, and utilization of 
evidence-based practices to translate into a CPG. Leadership skills and innovation have 
been part of the foundation to promote new knowledge to impact the clinical practice and 
patients’ outcomes promoting culture change through nursing knowledge translation and 
solving healthcare dilemmas and gaps in practice.  
 Evidence-based CPGs may help bridge the gap between research and practice. 
Accurate risk pressure injury is critical to ensure identification of the high-risk population 
and target risk factors that influence in the development of avoidable and unavoidable 
PUs. The consistency in the nursing documentation and timeliness in the care plan 
interventions will provide to support the prevention efforts to minimize risk for PU 
development (PU Prevention Toolkit: Joint Commission Resources, 2012). Adopt the 




were essential to advance to quality transformation of the preventing PU/PI. Culture 
change have been achieved through nursing education which influenced in positive 
attitudes about value of implementation of clinical guidelines.                                                                                                   
     Summary 
 PUs are considered to be an avoidable injury and continue be a key quality 
indicator (National Patient Safety Agency (NPSA) 2010, NHS Improving Quality (2009), 
and as the goal to prevent PUs remains essential, the number of PUs classified as 
preventable remains uncertain. A better understanding of the relation of modifiable and 
no modifiable contribution risk factors and the development of PUs can improve ability 
to identify patients at high risk to enable better target resources in clinical practice 
(Coleman, 2013). EBP will creates a view of nursing care as a framework for improving 
healthy environments and developing a vision of a systematic method for generating 
nursing interventions and care based on evidence (Omery & Williams, 1999).  
   The link between the evidence-based improvement intervention (e.g., the 
application of the CPG) and the outcome to be assessed needs to be clear. Even with clear 
linkages, at least seven challenges have been identified that interfere in one’s ability to 
trace a direct relationship between the cause (application of an evidence-based 
intervention) and its effect (effect on the outcome of interest; Minnick, 2009). Using 
evidence-based practice guidelines based on the translation of research to practice and 
now to policy, is important to standardizing and improving access to appropriate 




be called on to use all available methods to improve the quality and safety of health care 
delivered so that the most important outcome, patient health, is optimized. 
    Conclusions 
 The CPG Differentiating risks factors associated with the development of 
avoidable and unavoidable pressure ulcers (pressure injuries), is the first step in the 
literature that incorporate a screening process tool that combine and define intrinsic and 
extrinsic risk factors to identify the population at risk to develop avoidable and 
unavoidable PU. This CPG creates the opportunity to clinicians to incorporate a new 
standard of care to evaluating risk factors centered on the patient’ health condition, 
preferences and environmental factors. A new screening approach that integrates a new 
vision to evaluate patient’s risk factors from the use of a numeric category of risk 
interpretation to a comprehensive individualized perspective will produce a new evidence 
for PU advanced prevention and clinical strategies. The inclusion of the critical thinking 
process to provide conclusions of who is at risk and why is at risk to develop unavoidable 
and unavoidable PU will change the routine clinical process into a new standard of care. 
The use of this new instrument initiates a process to prove how a CPG support to identify 
high-risk population and target risk factors that influence in the development of avoidable 
and unavoidable PU. This CPG will provide structure that support nurses’ decision 
process and knowledge needed to implement timely and appropriate prevention plan to 
ensure consistency and precise risk factors documentation in circumstances when PU 
development requires to be defined as avoidable versus unavoidable. Data from further 




founded on a holistic perspective can help to decrease the incidence of avoidable PUs. 
The CPG: Differentiating risks factors associated with the development of avoidable and 
unavoidable pressure ulcers (pressure injuries), emphasize nursing appropriate and 
specific competencies to make informed decisions using critical think when identify and 
describe patients at risk to develop preventable and not preventable PUs. 
The foundation for the implementation of a reliable and effective prevention 
guidelines require individualized risk management incorporating a comprehensive risk 
factors tool (Joint Commission Resource, 2012). A better understanding of the relation of 
contribution risk factors and the development of PUs can improve ability to identify 
patients at high risk and would enable to better target resources in practice. Interventions 
guided towards the application of CPGs must embrace strategies to help, educate and 
empower clinicians to practice using evidence base. Applicability of research into 
practice evaluating PU risk profile categorization and patients’ outcomes can lead to 
more research on preventative measures to implement better treatment modalities.  
Accurate and comprehensive documentation is essential for effective prevention 
and management of PUs. Ayello et al., 2009 state that “good documentation must be 
comprehensive, consistent, concise, chronological, continuing and also reasonably 
complete.” Other specialists agree that documentation provides essential vision to 
clinicians and other stakeholders related the care interventions the patient received and 
their outcomes (i.e., assessment, prevention, treatment), and if a HAPU develops, denote 
that evidence-based care was offered to support that the HAPU was unavoidable 




after implementation of a quality improvement initiative to improve documentation of 
evidence-based interventions to prevent PUs, a 67% reduction in HAPUs were 
considered avoidable. The foundation and significance of documentation is further 
validated by CMS (2004, 2009, 2016) who has recognized that some PUs are 
unavoidable under evident circumstances, such as when the ulcers develop despite the 
provision of appropriate and accurate assessment and interventions. Consequently, for a 
PU to be considered unavoidable, there must be well-defined, a complete, and consistent 
documentation of the prevention and care interventions delivered to the patient is 
essential (Dahlstrom et al., 2011; Jacobson et al., 2016; Pittman et al., 2016; Worley, 
2007). Furthermore, the precision and quality of documentation is vital in any legal 
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Appendix A: Clinical Guideline Development- Using AGREE II 
 Clinical Practice Guideline Development requires a systematic method with 
inclusion and exclusion criteria to search the literature, and grade the strength of evidence 
(Moran, Burson, and Conrad, 2017). The Appraisal of Guidelines Research and 
Evaluation (AGREE) II provides the framework that the DNP student can use to guide 
the development of Clinical Practice Guidelines and to assess the quality of the guideline 
developed. The AGREE II is both valid and reliable and consists of 23 key items 
organized within six domains (http://www.agreetrust.org). The six domains include: 
Domain 1: Scope and purpose 
Description: The Scope and Purpose domain is concerned with the overall aim of the 
guideline, the specific health questions and the target population. 
Items: 
1. The overall objective(s) of the guideline is (are) specifically described. 
The Clinical Practice Guideline (CPG): Differentiating risk factors associated with the 
development of avoidable and unavoidable pressure ulcers (pressure injuries) is an 
evidence-based clinical guide used to assess, identify and differentiate the patient’s 
intrinsic and extrinsic risk factors related to the development of PUs. This CPG 
recognizes nursing assessment as a continuous process in the clinical practice. The use of 
this CPG will assist nursing to screen high-risk population profile taking in consideration 
the risk factors associated with the development of avoidable or unavoidable PUs. This 
guideline will provide a structure to identify and differentiate multifactorial intrinsic and 




and unavoidable (non-preventable) pressure ulcers and specifying if extrinsic risk factors 
could be modifiable or unmodifiable. This Clinical Practice Guideline provides structure 
that support nurses’ decision process and knowledge needed to implement timely and 
appropriate prevention plan and to ensure consistency and precise risk factors 
documentation in circumstances when pressure ulcer development requires to be defined 
as avoidable versus unavoidable. 
The guideline criteria were focused on 2 domains: (1)- Intrinsic or Unmodifiable risk 
factors related to an underlying health condition or other factors that make a patient more 
vulnerable to develop pressure ulcers (The Joint Commission Resources, 2012). These 
factors include: the length of stay of the hospitalization, age, diseases and contributing 
factors, history of previous pressure ulcers, use of high risk medications, certain 
treatment or medical procedures, mental status, cultural and or religious beliefs 
conflicting with patient treatment; (2)- Extrinsic risk factors related to immediate 
environment that place patient at risk for developing pressure ulcers (The Joint 
Commission Resources, 2012). These factors include: nutritional deficiencies, impaired 
mobility, head of bed elevation, pressure, friction, shearing, moisture and patient habits. 
For extrinsic risk factors it has been provided the option to select if these risks could be 
modifiable or unmodifiable upon patient’s health condition. 
The health question(s) covered by the guideline is (are) specifically described. 
a. What modifiable (extrinsic) and non-modifiable (intrinsic) risk factors are 




b. What modifiable (extrinsic) and unmodifiable risk factors (intrinsic) influence in 
the development of avoidable versus unavoidable pressure ulcer development. 
3. The population (patients, pressure ulcerblic, etc.) to whom the guideline is meant to 
apply is specifically described. 
This guideline will be recommended to be used in adults and old age patients admitted to 
acute /or long-term care institutions that have been already identified as risk population 
for pressure ulcers development using a standardized risk assessment tool. 
Domain 2: Stakeholder involvement 
Description: This domain focuses on the extent to which the overall aim of the guideline 
was developed by the appropriate stakeholders and represents the views of its intended 
users. 
Items: 
4. The guideline development group includes individuals from all the relevant 
professional groups. 
This guideline was developed by the DNP student who possess the experience, 
competencies, and educational background as a WOCN and as board certified wound 
care nurse. 
5. The views and preferences of the target population (patients, pressure ulcerblic, etc.) 
have been sought. 
The target population is adult or old age patients with acute, chronic and/or terminal 





6. The target users of the guideline are clearly defined. 
The users will be licensed registered nurses with a bachelor’s degree as a minimum 
academic requirement. 
Domain 3: Rigor of development 
Description: This domain relates to the process used to gather and synthesize the 
evidence, the methods to formulate and update recommendations. 
Items: 
7. Systematic methods were used to search for evidence. A multilevel, systematic review 
approach was taken to identify and synthesize the literature that meets the eligibility 
criteria to build an evidence-based scientific data related to PUs risk factors. 
8. The criteria for selecting the evidence are clearly described. 
A systematic approach was taken to identify the scientific evidence for the criteria that 
the literature recognizes as risk factors in the development of PUs. To increase the 
possibility that significant empirical and scientific evidence were incorporated in the final 
evidence-based criteria, the author conducted the review of the literature by 
systematically searching literature using relevant key words and then summarized the 
primary findings of articles that met standard inclusion criteria retrieved from systems 
that provided access to articles in the domains as systematic reviews, qualitative research, 
existing federal and state guidelines, national and organizational consensus, and as well 
as professional regulations in nursing practice: Pressure ulcer PubMed 
(www.ncbi.nlm.nih.gov/sites/entrez). To locate publications the following databases were 




PsycINFO-American Psychological Association, CINAHL database (Cumulative Index 
to Nursing & Allied Health Literature), MEDLINE/PubMed Resources Guide, Cochrane 
library, ERIC (Education Resources Information Center), TRIP database (Turning 
Research into Practice). Peer-reviewed articles published between 1970 and 2018 were 
inquired in the 3 search mechanisms. Key words were selected with the intent of 
including all possible articles that might have been relevant to the questions of interest. 
The principal concept included the following terms: “pressure ulcer risk factors”, 
“avoidable or unavoidable pressure ulcers” and “factors lead to pressure ulcer 
development” A second, independent concept was conducted to identify articles related 
to modifiable and unmodifiable pressure ulcer risks. For this concept, the same search 
terms were used as in the previous procedure along with the additional condition term 
“avoidable versus unavoidable pressure ulcers” to allow for the inclusion of studies of 
high risk factors considered in the development of avoidable and unavoidable pressure 
ulcers.                                                                        
9. The strengths and limitations of the body of evidence are clearly described. To 
compiling evidence and assessing evidence for quality the student used Fineout-Overholt, 
Melynk, Stillwell, and Williamson literature assessment for levels of evidence. When 
data were lacking, particularly in the risk factors categorization, a combination of 
recommendations developed by expert external organizations (Centers for Medicare and 
Medicaid Services (CMS), The Joint Commission, the Wound Ostomy Continence Nurse 




consensus were adopted.                                                                                                                                         
10. The methods for formulating the recommendations are clearly described.                  
A systematic approach was taken to capture the impact of several prognostic variables on 
pressure ulcer development. These variables were classified in two categories: intrinsic 
and extrinsic risks factors supporting nurses’ competence in the identification, description 
and documentation of modifiable and unmodifiable risk factors associated with pressure 
ulcers development. This guide integrates scientific knowledge to improve skill to 
differentiate in high-risk population the factors that influence in the development of 
avoidable (preventable) and unavoidable (non-preventable) PUs, providing consistency 
and appropriate nursing documentation in circumstances when a pressure ulcer is 
identified as unavoidable.                                                                                                   
11. The health benefits, side effects and risks have been considered in formulating the 
recommendations. The Clinical Practice Guideline (CPG) is intended to assist nurses to 
identify and differentiate multifactorial intrinsic and extrinsic patient risk factors 
associated with the development of avoidable (preventable) and unavoidable (non-
preventable) PUs identifying if these risk factors are modifiable or unmodifiable. This 
Clinical Practice Guideline provides structure that support nurses’ decision process and 
knowledge needed to implement timely and appropriate prevention plan and ensure 
consistency and precise risk factors documentation in circumstances when pressure ulcer 
development requires to be defined as avoidable versus unavoidable. 
Patient’s risk factors that are inappropriately categorized as modifiable or unmodifiable 




ulcer development.                                                                                                                                
12. There is an explicit link between the recommendations and the supporting evidence. 
It is considered that the etiology of pressure ulcers (injuries) is a complex process relating 
multiple, often non-modifiable, intrinsic risk factors, which are not entirely categorized 
by assessment tools (Berlowitz & Brienza, 2007; Edsberg et al., 2014; Lyder, 2003; 
Registered Nurses Association of Ontario [RNAO], 2011). The incidence of avoidable 
pressure ulcers is recognized as an important performance indicator of quality care 
(Fletcher 2014, Stephen-Haynes 2014). For quality improvement, such indicators must be 
reinforced by evidence-based standards of care. Mainz (2003) stated that clinical 
indicators should relate to structure, procedure and result. However, the structure partly 
implies the service within the organizational structure, the procedure or process 
represents the guidelines of the care delivery related to pressure ulcer prevention, and the 
result specifies the achievement of that clinical practice related to the exclusion of 
avoidable pressure ulcers development. The need for strategies and standards for practice 
encompasses the creation and implementation of new documentation to incorporate 
multidimensional risk identification and prevention (Parnham, 2015).                            
13. The guideline has been externally reviewed by experts prior to its publication. Once 
the content of the clinical practice guideline be validated the final guideline will be 
converted into a document that meets publication requirements.                                                               
14. A procedure for updating the guideline is provided. This guideline contains the 
modifiable and unmodifiable pressure ulcer risk factors best supported by evidence and 




health related conditions and circumstances once new scientific data is obtained, but 
changes will not be available until at least 1 year after the publication of this current 
guideline. An anticipated change in the age of patient for when is considered at risk to 
develop pressure ulcer could be take in consideration upon the care setting in which the 
guideline is applied.                                                                                                         
Domain 4: Clarity of presentation                                                                        
Description: This domain deals with the language, structure and format of the guideline. 
Items:                                                                                                                                    
15. The recommendations are specific and unambiguous.                                                 
The use of the CPG: Differentiating risks factors associated with the development of 
avoidable and unavoidable pressure ulcers (pressure injuries), is an evidence-based 
guideline to ensure identification of the high-risk population and target risk factors that 
influence in the development of avoidable and unavoidable pressure ulcers (pressure 
injuries).                                                                                                                                   
16. The different options for management of the condition or health issue are clearly 
presented.   
The CPG is recommended in high-risk populations defined by the use of a standardized 
risk assessment tool. Patients at risk for pressure ulcer development should commence 
screening after initial pressure ulcer risk assessment has been performed to differentiate 
specific risks factors associated with the development of avoidable and unavoidable 
pressure ulcers followed when a change in condition is presented in patient’s health 




17. Key recommendations are easily identifiable.                                                             
The CPG will provide understanding of integrating the analysis of the modifiable and 
unmodifiable risk factors to define clinical situations that contribute to pressure ulcer 
unavoidability. The guideline was systematically developed to provide consistency and 
appropriate nursing documentation that support nurses’ decision process and knowledge 
needed to implement appropriate care plan that support the nursing interventions and 
define circumstances when an unavoidable pressure ulcer can result.                                                                                                                                               
Domain 5: Applicability                                                                                           
Description: This domain pertains to the likely barriers and facilitators to implementation, 
strategies to improve uptake, and cost implications of applying the guideline.             
Items:                                                                                                                                         
18. The guideline describes facilitators and barriers to its application.                               
The guideline integrates explicit clinical terminology consistent with nurses’ educational 
background and integrate the process of the nursing assessment and documentation. Costs 
implications for adaptability on data system, nursing time and resistance to change could 
be considered as potential barriers. The application of this new initiative required the 
support and participation of the facility stakeholders’, and educational activities to 
reinforce on the clinical staff the reasons and use of this guideline.                                                                 
19. The guideline provides advice and/or tools on how the recommendations can be place 
into practice.                                                                                                                        
The guideline will provide the categorization of intrinsic and or extrinsic risk factors 




20. The potential resource implications of applying the recommendations have been 
considered. 
The identification of intrinsic and extrinsic patient’s risks factors for pressure ulcers 
development will support the implementation of a higher standard of care in the nursing 
practice. This will allow nursing to implement the use of an evidence-based system 
making accurate identification and documentation to help define avoidable versus 
unavoidable pressure ulcers development. 
21. The guideline presents monitoring and/or auditing criteria. 
Patient’s assessment and documentation is a continuous nursing process which include 
the revision of patient’s needs, evaluate progress and identify potential risks in the 
patient’s health status. This guideline would be applied as a quality improvement 
measurement/indicator to define/categorize the incidence of acquired pressure ulcers at 
the organization, and monitoring safety and compliance with patients’ standards of care. 
Domain 6: Editorial independence 
Description: This domain is concerned with the formation of recommendations not being 
unduly biased with competing interests. 
Items: 
22. The views of the funding body have not influenced the content of the guideline. 
No funding body applied. 






Appendix B: Clinical practice guideline: Differentiating risks factors associated with the 
development of avoidable and unavoidable pressure ulcers (pressure injuries) 
 The Clinical Practice Guideline (CPG): Differentiating risk factors associated 
with the development of avoidable and unavoidable pressure ulcers (pressure injuries) is 
an evidence-based clinical guide used to assess, identify and differentiate the patient’s 
intrinsic and extrinsic risk factors related to the development of pressure ulcers. This 
CPG recognizes nursing assessment as a continuous process in the clinical practice. The 
use of this CPG will assist nursing to screen high-risk population taking in consideration 
the risk factors associated with the development of avoidable or unavoidable pressure 
ulcers. This guideline will offer a structure to identify and differentiate multifactorial 
intrinsic and extrinsic patient risk factors associated with the patient health profile. This 
Clinical Practice Guideline intend to provide structure that support nurses’ decision 
process and knowledge needed to implement timely and appropriate prevention plan and 
ensure consistency documentation in circumstances when pressure ulcer development 
must be classify as avoidable versus unavoidable. 
 The guideline criteria are focused on 2 domains: (1)- Intrinsic or Unmodifiable 
risk factors related to an underlying health condition or other factors that make a patient 
more vulnerable to develop pressure ulcers (The Joint Commission Resources, 2012). 
These factors include: the length of stay of the hospitalization, age, diseases and 
comorbidities, history of previous pressure ulcers, use of high risk medications, certain 
treatment and medical procedures, mental status, cultural and or religious beliefs 




immediate environment that place patient at risk for developing pressure ulcers (The Joint 
Commission Resources, 2012). These factors include: nutritional deficiencies, impaired 
mobility, head of bed elevation, pressure, friction, shear, moisture and patient habits. For 
both risk factors categories (intrinsic and extrinsic) it has been provided the option to 
select if these risk factors are modifiable or unmodifiable upon patient’s health condition. 
Table 1.0  
Rating System for the Hierarchy of Evidence 
Evidence Rating Evaluation Criteria 
Level I Evidence from a systematic review or meta-analysis of all relevant  
randomized controlled trials (RCTs), or evidence-based clinical  
practice guidelines based on systematic reviews of RCTs 
Level II Evidence obtained from at least one well-designed RCT 
Level III Evidence obtained from well-designed controlled trials without 
randomization 
Level IV Evidence from well-designed case-control and cohort studies 
Level V Evidence from systematic reviews of descriptive and qualitative  
studies 
Level VI Evidence from a single descriptive or qualitative study 
Level VII Evidence from the opinion of authorities and/or reports of expert  
committees 
 
Table 1.2  
 
Grading the Quality of the Evidence 
 
I. Acceptable Quality: No concerns 
II. Limitations in Quality: Minor flaws or inconsistencies in the evidence 
III. Major Limitations in Quality: Many flaws and inconsistencies in the evidence 
IV. Not Acceptable: Major flaws in the evidence 
 
 
Table 1.3  
 





Level A Recommendations: High 
• Reflects a high degree of clinical certainty 
• Based on availability of high quality Level I, II and/or III evidence available using 
Melnyk & Fineout-Overholt grading system  
• Based on consistent and good quality evidence; has relevance and applicability to 
nursing practice 
• Is beneficial 
Level B Recommendations: Moderate 
• Reflects moderate clinical certainty 
• Based on availability of Level III and/or Level IV and V evidence using Melnyk & 
Fineout-Overholt grading system  
• There are some minor flaws or inconsistencies in quality of evidence; has relevance 
and applicability to nursing practice 
• Is likely to be beneficial 
Level C Recommendations: Weak 
• Level V, VI and/or VII evidence available using Melnyk & Fineout-Overholt 
grading system 
• Based on consensus, usual practice, evidence, case series for studies of treatment or 
screening, anecdotal evidence, and/or opinion 
• There is limited or low-quality patient-oriented evidence; has relevance and 
applicability to nursing practice 
• Has limited or unknown effectiveness 
Not Recommended for Practice 
• No objective evidence or only anecdotal evidence available; or the supportive 
evidence is from poorly controlled or uncontrolled studies 
• Other indications for not recommending evidence for practice may include: 
o Conflicting evidence 
o Harmfulness has been demonstrated 
o Cost or burden necessary for intervention exceeds anticipated benefit 
o Does not have relevance or applicability to emergency nursing practice 
 
• There are certain circumstances in which the recommendations stemming from 
a body of evidence should not be rated as highly as the individual studies on 
which they are based. For example: 
o Heterogeneity of results 
o Uncertainty about effect magnitude and consequences 
o Strength of prior beliefs 





Clinical practice guideline: Differentiating risks factors associated with the development 
of avoidable and unavoidable pressure ulcers (pressure injuries) 
 
Intrinsic or Unmodifiable Risk Factors 
1. 1. Time of hospitalization (LOS) > 5 days   
2. Level B- Moderate (Cox, 2011; Rogenski and Santos, 2005; Eachempati et al., 2001). 
3.  
4. 2. Age 70 years or more  
5. Level B - Moderate (Stojadinovic et al., 2013); Allman, 1989; Cox, 2011; Cox, 2017; Perier 
et al., 2002; Lyder et al., 2012; Eachempati et al., 2001; Baumgarten et al., 2006; Bours et 
al., 2001).  
6.                                         
7. 3. Patient health status: 
(   ) Chronic disease   
Level B- moderate (Lyder et al., 2012).  
 
(  ) Critically ill   
Level A- High (Coyer & Nahla, 2017; Cox, 2017; Rao et al 2016; Delmore et al., 2015).  
 
(  )Terminal condition 
 Level A- High (Langemo & Brown, 2006). 
 
Contributing factors: 
(   ) Cardiovascular disease   
Level A- Moderate (Cox et al., 2017; Van Marum et al., 2001). 
 
(   ) Cerebrovascular disease  
Level B- Moderate (Lyder et al., 2012); Van Marum, 2001). 
 
(   ) Peripheral vascular disease 
Level – A- High (Thomas et al., 1999). 
 
(   ) Respiratory Failure  
Level A- High (Cox, 2017; Delmore et al., 2015; Yamaguti et al., 2014). 
 
(   ) Acute/Chronic- Renal failure  
Level B- Moderate (Becker et al., 2017; Larson et al., 2012; Levine et al., 2009). 
 
(   ) Liver dysfunction  
Level A- High (Delmore et al., 2015). 
 
(   ) Sensorial  dysfunction  






(   ) Diabetes  
Level A- (Brandeis et al., 1994; Berlowitz and Wilking, 1989; Cox, 2017; Ooiet al., 1999; 
Stordeur et al., 1998; Halfens et al., 2000; Feuchtinger et al., 2006; Nixon et al., 2006; 
Donnelly, 2006; Schultz et al., 1999; Rademakers et al., 2007; Vanderwee et al., 2009; 
Compton et al., 2008). 
 
(   ) Obesity / Morbid obesity   
Level B- Moderate (Compher et al., 2007). 
 
(   ) Severe anemia 
 Level B- Moderate (Levine et al., 2009). 
 
(   ) Hemodynamic instability                                                                                                                   
Level B- Moderate (Shanks, Kleinhelter, Baker, 2009; Langemo & Brown, 2006). 
(   ) Body edema /anasarca 
Level B- Moderate (Margolis et al., 2003; Exton-Smith and Sherwin, 1961; Zaratkiewicz et 
al., 2010). 
 
(   ) Infection / Sepsis  
Level B- Moderate (Curry et al., 2012); Levine et al., 2009; Redelings, Lee, Sorvillo, 2005). 
 
(   ) Multiple organ failure    
Level B: Moderate (Beare, Myers, 1998). 
   
(   ) Hip fracture                                                                                                                                          
Level B- moderate (Chiari,2017; Baumgarten et al., 2009; Maher et al., 2013; Lindholm et 
al., 2008).  
     
(   ) History of previous PRESSURE ULCER 
Level B- Moderate (Lyder et al., 2012). 
 
(   ) Burns  
Level A- (Ladd, Ekanem & Caffrey, 2018). 
 
8. 4. Use of medical devices / equipment 
9. Level A- High (VanGilder et al., 2009; Holden-Mount & Sieggreen, 2015; Murray et al., 
2013). 
 
5. High Risk medications  




Level B- Moderate (Cox, 2011; Pittman et al., 2016; Cox& Roche, 2015). 
 
(   ) Hypotensive  
Level B- Moderate (Levine et al., 2009). 
 
(   ) High dose of steroids  
Level B- Moderate (Lyder et al., 2012). 
 
(   ) Sedatives  
Level B- Moderate (Levine et al., 2009; Pittman et al., 2016; Nedergaard et al., 2018). 
 
(   ) Anesthetics 
Level B- Moderate (Primiano et al., 2011; Armstrong and Bortz, 2001). 
 
6. 6. Surgical procedure > or = 4 hours  
Level A- High (Schoonhoven et al., 2002; Connor et al., 2010). 
 
7. Altered Mental status    
Level C- Weak (Garcia-Fernandez et al: 2014). 
 
8. End stage dementia   
Level B- Moderate (Margolis et al., 2003). 
 
8. 8. Patient cultural and/or religious belief conflicting with patient treatment or Refuse 
treatment    
Level A- High (Goodman et al., 1999). 
 
Extrinsic or Modifiable Risk Factors  
1. 1. Nutritional impairments   
2. Level B- Moderate (Fry et al., 2010; Perier et al., 2002; Shahin et al., 2010).   
3.   
4. 2. Impaired Mobility  
5. Level B- Moderate (Lindgren, 2004). 
6.                   
7. 3. Head-of-bed (HOB) elevation of 30 grade or more 
8. Level A-High (Peterson et al., 2008). 
9.  
4. Pressure           Sources:    (  ) surface   (   ) medical device 
Level A- High (Seiler & Stahelin, 1979; Gawlitta et al., 2007; Ahmed et al., 2016; Breuls et 
al., 2003; Kawamata et al., 2015). 
 
5. Friction            Sources:    (  ) surface   (   ) medical device 






Level A- High (Wert et al., 2015; Kenichi et al., 2014)  
 
7. Moisture         (   ) urinary/fecal incontinence  (   ) wound exudate   (   ) sweat   
Level A- High (Bates-Jensen, McCreath, & Patlan, 2017); Shaked and Gefen, 2013; Sopher 
& Gefen,2011). 
 
8.Patient’s habits    (  ) smoking  





















Appendix C: Experts Panel Rating CPG domains using AGREE II criteria 
Domain 1: Scope & Purpose 100% 
 
1. The overall objective(s) of the guideline is (are) specifically described. 
2. The health question(s) covered by the guideline is (are) specifically described. 
3. The population (patients, pressure ulcerblic, etc.) to whom the guideline is meant to 
apply is specifically described. 
Table 1.0 
Domain 1: Scope & Purpose 
Appraiser Item 1 Item 2 Item 3 Total 
1 7 7 7 21 
2 7 7 7 21 
3 7 7 7 21 
4 7 7 7 21 
5 7 7 7 21 
6 7 7 7 21 
7 7 7 7 21 
8 7 7 7 21 
Total 56 56 56 168 
 
Maximum possible score = 7 x 3 x 8 = 168 
Minimum possible score = 1 x 3 x 8 = 24 
 
168 - 24 
________     =   144/144 = 100% 












Domain 2. Stakeholder Involvement 94.4% 
 
4. The guideline development group includes individuals from all relevant professional 
groups. 
5. The views and preferences of the target population (patients, pressure ulcerblic, etc.) 
have been sought. 
6. The target users of the guideline are clearly defined. 
Table 1.2 
Domain 2. Stakeholder Involvement 
Appraiser Item 4 Item 5 Item 6 Total 
1 6 7 7 20 
2 6 7 7 20 
3 6 7 7 20 
4 6 7 7 20 
5 6 7 7 20 
6 6 7 7 20 
7 6 7 7 20 
8 6 7 7 20 
Total 48 56 56 160 
 
Maximum possible score 7 x 3 x 8 = 168 
Minimum possible score 1 x 3 x 8 = 24 
160 - 24     =   136/144 = 94.4% 
168 - 24 
    
Domain 3: Rigor of Development 99.7% 
 
7. Systematic methods were used to search for evidence. 
8. The criteria for selecting the evidence are clearly described. 
9. The strengths and limitations of the body of evidence are clearly described. 




11. The health benefits, side effects, and risks have been considered in formulating the 
recommendations. 
12. There is an explicit link between the recommendations and the supporting evidence. 
13. The guideline has been externally reviewed by experts prior to its publication. 
14. A procedure for updating the guideline is provided. 
Table 1.3 


















1 7 7 7 7 7 6 7 7 55 
2 7 7 7 7 7 7 7 7 56 
3 7 7 7 7 7 7 7 7 56 
4 7 7 7 7 7 7 7 7 56 
5 7 7 7 7 7 7 7 7 56 
6 7 7 7 7 7 7 7 7 56 
7 7 7 7 7 7 7 7 7 56 
8 7 7 7 7 7 7 7 7 56 
Total 56 56 56 56 56 55 56 56 447 
 
Maximum possible score 7 x 8 x 8 = 448 
Minimum possible score 1 x 8 x 8 = 64 
447- 64         = 383/384 = 99.7% 
448-64 
 
Domain 4. Clarity of Presentation 99.3% 
 
15. The recommendations are specific and unambiguous. 
16. The different options for management of the condition or health issue are clearly 
presented. 







Domain 4. Clarity of Presentation 
 
Appraiser Item 15 Item 16 Item 17 Total 
1 7 7 7 21 
2 7 6 7 20 
3 7 7 7 21 
4 7 7 7 21 
5 7 7 7 21 
6 7 7 7 21 
7 7 7 7 21 
8 7 7 7 21 
Total 56 55 56 167 
 
Maximum possible score 7 x 3 x 8 = 168 
Minimum possible score 1 x 3 x 8 = 24 
167-24  
168-24 = 143/144 = 99.3 x 100 = 99.3% 
 
Domain 5. Applicability 100% 
 
18. The guideline describes facilitators and barriers to its application. 
19. The guideline provides advice and/or tools on how the recommendations can be 
placed into practice. 
20. The potential resource implications of applying the recommendations have been 
considered. 




Domain 5. Applicability 
 
Appraiser Item 18 Item 19 Item 20 Item 21 Total 
1 7 7 7 7 28 




3 7 7 7 7 28 
4 7 7 7 7 28 
5 7 7 7 7 28 
6 7 7 7 7 28 
7 7 7 7 7 28 
8 7 7 7 7 28 
Total 56 56 56 56 224 
 
 
Maximum possible score 7 x 4 x 8 = 224 
Minimum possible score 1 x 4 x 8 = 32 
 
224 -32      = 192/192 = 1 x 100 = 100% 
224-32  
 
Domain 6. Editorial Independence 100% 
  
22. The views of the funding body have not influenced the content of the guideline. 
23. Competing interests of guideline development group members have been recorded 
and addressed. 
Table 1.6  
Domain 6. Editorial Independence 
Appraiser Item 22 Item 23 Total 
1 7 7 14 
2 7 7 14 
3 7 7 14 
4 7 7 14 
5 7 7 14 
6 7 7 14 
7 7 7 14 
8 7 7 14 
Total 56 56 112 
 
Maximum possible score 7 x 2 x 8 = 112 
Minimum possible score 1 x 2 x 8 = 16 
 
112-12    = 100/100 = 1 x 100 = 100% 
112-12  
